<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="ebd" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">ebd</book-part-id>
      <title-group>
        <title>Dystrophic Epidermolysis Bullosa</title>
        <alt-title alt-title-type="alt-title">Synonyms: DEB, Epidermolysis Bullosa Dystrophica</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Pfendner</surname>
            <given-names>Ellen G</given-names>
          </name>
          <degrees>PhD</degrees>
          <aff>Director, EBDx Program<break/>GeneDx, Inc<break/>Gaithersburg, Maryland</aff>
          <email>ellen@genedx.com</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Lucky</surname>
            <given-names>Anne W</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Medical Director, Cincinnati Children's Epidermolysis Bullosa Center<break/>Cincinnati Children's Hospital<break/>Cincinnati, Ohio</aff>
          <email>annelucky@fuse.net</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>21</day>
          <month>8</month>
          <year>2006</year>
        </date>
        <date date-type="updated">
          <day>26</day>
          <month>2</month>
          <year>2015</year>
        </date>
        <date date-type="revised">
          <day>4</day>
          <month>10</month>
          <year>2007</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="hmdpc" document-type="chapter">Dystonia/Parkinsonism, Hypermanganesemia, Polycythemia, and Chronic Liver Disease</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="dbmd" document-type="chapter">Dystrophinopathies</related-object>
      <abstract id="ebd.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Dystrophic epidermolysis bullosa (DEB) comprises two types based on inheritance pattern:</p>
          <list list-type="bullet">
            <list-item>
              <p>Recessive DEB, including severe generalized (RDEB-sev gen; formerly called Hallopeau-Siemens type [RDEB-HS]) and generalized other (RDEB-O; formerly called non-Hallopeau-Siemens type [RDEB-non-HS])</p>
            </list-item>
            <list-item>
              <p>Dominant DEB (DDEB)</p>
            </list-item>
          </list>
          <p>In RDEB-sev gen, blisters affecting the whole body may be present in the neonatal period. Oral involvement may lead to mouth blistering, fusion of the tongue to the floor of the mouth, and progressive diminution of the size of the oral cavity. Esophageal erosions can lead to webs and strictures that can cause severe dysphagia. Consequently, severe nutritional deficiency and secondary problems are common. Corneal erosions can lead to scarring and loss of vision. Blistering of the hands and feet followed by scarring fuses the digits into "mitten" hands and feet, a hallmark of this disorder. The lifetime risk of aggressive squamous cell carcinoma is higher than 90%.</p>
          <p>In contrast, the blistering in the less severe forms of RDEB-O may be localized to hands, feet, knees, and elbows with or without involvement of flexural areas and the trunk, and without the severe, mutilating scarring seen in RDEB-sev gen.</p>
          <p>In DDEB, blistering is often mild and limited to hands, feet, knees, and elbows, but nonetheless heals with scarring. Dystrophic nails, especially toenails, are common and may be the only manifestation of DDEB.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The only gene in which mutation is known to cause DEB is <italic toggle="yes">COL7A1</italic>. Sequencing of exons 73, 74, and 75 of <italic toggle="yes">COL7A1</italic> detects pathogenic variants in 75% of families with DDEB; sequencing of all coding exons detects pathogenic variants in about 95% of individuals with either DDEB or RDEB. In the absence of a confirmatory molecular diagnosis, examination of a skin biopsy by transmission electron microscopy (EM) and/or immunofluorescent (IF) antibody/antigen mapping can help to establish the diagnosis.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> New blisters should be lanced, drained, and in most cases dressed with a non-adherent material, covered with padding for stability and protection, and secured with an elastic wrap for integrity. Infants and children with RDEB-sev gen and failure to thrive require attention to fluid and electrolyte balance and may require nutritional support, including feeding gastrostomy. Anemia is treated with iron supplements and transfusions as needed. Other nutritional supplements may include calcium, vitamin D, selenium, carnitine, and zinc. Occupational therapy may help prevent hand contractures. Surgical release of fingers often needs to be repeated.</p>
          <p><italic toggle="yes">Prevention of primary manifestations:</italic> Dressings and padding are needed to protect bony prominences from blister-inducing impact; if a fetus is known to be affected with any form of DEB, cesarean delivery may reduce trauma to the skin during delivery.</p>
          <p><italic toggle="yes">Prevention of secondary complications:</italic> The most common secondary complication is infection; treatment of chronic wound infection with both antibiotics and antiseptics is necessary.</p>
          <p><italic toggle="yes">Surveillance</italic>: Beginning in the second decade of life, biopsies of abnormal-appearing wounds that do not heal or have exuberant scar tissue are indicated for evidence of squamous cell carcinoma. Screening for deficiencies of iron, zinc, vitamin D, selenium, and carnitine should start after the first year of life. Routine echocardiograms are recommended to identify dilated cardiomyopathy and bone mineral density studies to identify osteoporosis.</p>
          <p><italic toggle="yes">Agents/circumstances to avoid:</italic> Activities/bandages that traumatize the skin; all adhesives.</p>
          <p><italic toggle="yes">Evaluation of relatives at risk:</italic> Evaluating an at-risk newborn for evidence of blistering is appropriate so that trauma to the skin can be avoided as much as possible.</p>
          <p><italic toggle="yes">Pregnancy management:</italic> Cesarean section is often recommended to avoid vaginal delivery in a fetus at risk.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>Dystrophic epidermolysis bullosa is inherited in either an autosomal dominant (DDEB) or autosomal recessive (RDEB) manner. Molecular characterization of pathogenic variants is the only accurate method to determine mode of inheritance and recurrence risk; phenotype severity and EM/IF findings alone are not sufficient.</p>
          <list list-type="bullet">
            <list-item>
              <p>DDEB. About 70% of individuals diagnosed with DDEB are reported to have an affected parent. If a parent of a proband with DDEB is affected, the risk to the sibs is 50%. Each child of an individual with DDEB has a 50% chance of inheriting the pathogenic variant.</p>
            </list-item>
            <list-item>
              <p>RDEB. Each sib of an affected individual whose parents are both carriers has at conception a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier.</p>
            </list-item>
          </list>
          <p>If the pathogenic variant(s) have been identified in an affected family member, prenatal testing for pregnancies at increased risk may be available from a clinical laboratory that offers either testing for this disease/gene or custom prenatal testing.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="ebd.GeneReview_Scope">
        <title><italic toggle="yes">GeneReview</italic> Scope</title>
        <table-wrap id="ebd.Tc" orientation="portrait" position="anchor">
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_ebd.Tc_1_1_1_1" valign="top" align="left" scope="col" rowspan="1" colspan="1">Dystrophic Epidermolysis Bullosa: Included Disorders</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_ebd.Tc_1_1_1_1" valign="top" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Recessive dystrophic epidermolysis bullosa (RDEB)</p></list-item><list-item><p>Dominant dystrophic epidermolysis bullosa (DDEB)</p></list-item></list>
</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>For synonyms and outdated names see <xref ref-type="sec" rid="ebd.Nomenclature">Nomenclature</xref>.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec id="ebd.Diagnosis">
        <title>Diagnosis</title>
        <sec id="ebd.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>The diagnosis of dystrophic epidermolysis bullosa (DEB) <bold>is suspected</bold> in individuals with the following clinical findings:</p>
          <list list-type="bullet">
            <list-item>
              <p>Fragility of the skin, manifest by blistering with little or no trauma, which heal with milia and scarring.</p>
            </list-item>
            <list-item>
              <p>Blistering that:</p>
              <list list-type="bullet">
                <list-item>
                  <p>May be present in the neonatal period</p>
                </list-item>
                <list-item>
                  <p>Can affect the whole body (most severe forms) or primarily the hands, feet, knees, and elbows (milder forms)</p>
                </list-item>
                <list-item>
                  <p>Can lead to mutilating pseudosyndactyly of the hands and feet (severe forms)</p>
                </list-item>
                <list-item>
                  <p>Can lead to oral and/or laryngeal scarring and webbing</p>
                </list-item>
                <list-item>
                  <p>Can lead to corneal erosions with resulting scarring leading to loss of vision</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Dystrophic nails, especially toenails, or absent nails</p>
            </list-item>
            <list-item>
              <p>Family history that is consistent with either an autosomal recessive or an autosomal dominant inheritance pattern</p>
            </list-item>
          </list>
          <p>Note: (1) Dystrophic epidermolysis bullosa (DEB) is divided into two major types depending on inheritance pattern: recessive dystrophic epidermolysis bullosa (RDEB) and dominant dystrophic epidermolysis bullosa (DDEB). Each type is further subdivided into multiple clinical subtypes (see <xref ref-type="sec" rid="ebd.Nomenclature">Nomenclature</xref>). (2) Absence of a known family history of DEB does not preclude the diagnosis.</p>
        </sec>
        <sec id="ebd.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>Because the clinical features of all types of epidermolysis bullosa overlap significantly, clinical diagnosis alone is unreliable. Molecular genetic testing of <italic toggle="yes">COL7A1</italic> is usually required to establish the diagnosis, especially in infants (see <xref ref-type="fig" rid="ebd.F1">Figure 1</xref> and <xref ref-type="table" rid="ebd.T.summary_of_molecular_genetic_testi">Table 1</xref>). If molecular genetic testing is not diagnostic, examination of a skin biopsy may be necessary.</p>
          <p>Note: Molecular genetic testing may also be used to establish the inheritance pattern in a particular family and to guide future reproductive decisions by enabling prenatal diagnosis for the affected fetus and family members (see <xref ref-type="sec" rid="ebd.Genetic_Counseling">Genetic Counseling</xref>). Some pathogenic variants in <italic toggle="yes">COL7A1</italic> have been described in both recessive and dominant inheritance patterns [<xref ref-type="bibr" rid="ebd.REF.almaani.2011.262">Almaani et al 2011</xref>].</p>
          <p>Molecular testing approaches can include <bold>single-gene testing</bold>, use of a <bold>multi-gene panel</bold>, and <bold>more comprehensive</bold>
<bold>genomic testing</bold>.</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Single-gene testing.</bold> One strategy for the diagnosis of an individual suspected of having DEB is single-gene testing of <italic toggle="yes">COL7A1</italic>, beginning with sequence analysis.</p>
              <p>Note: For dominant DEB (DDEB):</p>
              <list list-type="bullet">
                <list-item>
                  <p>Although sequencing of exons with a known founder variant(s) in individuals of certain ethnic backgrounds has been described in European populations, such an approach has not been fruitful in the US population, in which more than 700 pathogenic variants have been found in any of the 118 exons of <italic toggle="yes">COL7A1.</italic></p>
                </list-item>
                <list-item>
                  <p>Targeted approaches that may be considered in European populations include sequence analysis of exons 73, 74, and 75 of <italic toggle="yes">COL7A1</italic> (which detects ~75% of the dominant DEB-causing pathogenic variants) as a first step. <italic toggle="yes">De novo</italic> and recurrent pathogenic variants, especially <xref ref-type="table" rid="ebd.T.selected_col7a1_pathogenic_variant">p.Gly2043Arg</xref> and <xref ref-type="table" rid="ebd.T.selected_col7a1_pathogenic_variant">p.Gly2034Arg</xref> in exon 73, have been described.</p>
                </list-item>
                <list-item>
                  <p>If no pathogenic variant is identified in exons 73-75, sequencing of the remaining coding exons is performed.</p>
                </list-item>
              </list>
              <p>If no pathogenic variant is identified &#x02013; or if only a single pathogenic variant is identified in an individual in whom recessive DEB is suspected &#x02013; deletion/duplication analysis of <italic toggle="yes">COL7A1</italic> can be considered next.</p>
            </list-item>
            <list-item>
              <p><bold>A multi-gene panel</bold> that includes <italic toggle="yes">COL7A1</italic> and other genes of interest (see <xref ref-type="sec" rid="ebd.Differential_Diagnosis">Differential Diagnosis</xref>) may also be considered. Note: (1) The genes included in the panel and the diagnostic sensitivity of the testing used for each gene vary by laboratory and over time. (2) Some multi-gene panels may include genes not associated with the condition discussed in this <italic toggle="yes">GeneReview</italic>; thus, clinicians need to determine which multi-gene panel provides the best opportunity to identify the genetic cause of the condition at the most reasonable cost.</p>
            </list-item>
            <list-item>
              <p><bold>More comprehensive genomic testing</bold> (when available) including exome sequencing, genome sequencing, and mitochondrial sequencing may be considered if serial single-gene testing (and/or use of a multi-gene panel) fails to confirm a diagnosis in an individual with features of DEB. Such testing may provide or suggest a diagnosis not previously considered (e.g., mutation of a different gene that results in a similar clinical presentation). For more information on comprehensive genome sequencing click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.Comprehensive_Genome_Sequencing" object-type="sec">here</related-object>.</p>
            </list-item>
          </list>
          <table-wrap id="ebd.T.summary_of_molecular_genetic_testi" orientation="portrait" position="anchor">
            <label>Table 1. </label>
            <caption>
              <p>Summary of Molecular Genetic Testing Used in Dystrophic Epidermolysis Bullosa</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_ebd.T.summary_of_molecular_genetic_testi_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_ebd.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Dystrophic EB Type</th>
                  <th id="hd_h_ebd.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_h_ebd.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of Probands with a Pathogenic Variant Detectable by This Method</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_ebd.T.summary_of_molecular_genetic_testi_1_1_1_1" rowspan="4" valign="middle" align="left" scope="row" colspan="1">
                    <italic toggle="yes">COL7A1</italic>
                  </td>
                  <td headers="hd_h_ebd.T.summary_of_molecular_genetic_testi_1_1_1_2" rowspan="2" valign="middle" align="left" colspan="1">Dominant DEB</td>
                  <td headers="hd_h_ebd.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>2,&#x000a0;3</sup></td>
                  <td headers="hd_h_ebd.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">95%&#x000a0;<sup>4</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_ebd.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>5</sup></td>
                  <td headers="hd_h_ebd.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;1%</td>
                </tr>
                <tr>
                  <td headers="hd_h_ebd.T.summary_of_molecular_genetic_testi_1_1_1_2" rowspan="2" valign="middle" colspan="1" align="left" scope="row">Recessive DEB</td>
                  <td headers="hd_h_ebd.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>2</sup></td>
                  <td headers="hd_h_ebd.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">95%&#x000a0;<sup>4</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_ebd.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>5</sup></td>
                  <td headers="hd_h_ebd.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;2%</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="ebd.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="ebd" object-id="ebd.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein. See <xref ref-type="sec" rid="ebd.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
              </fn>
              <fn id="ebd.TF.1.2">
                <label>2. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="ebd.TF.1.3">
                <label>3. </label>
                <p>Pathogenic variant detection rate in individuals with biopsy-diagnosed DEB is 95% [<xref ref-type="bibr" rid="ebd.REF.kern.2006.1006">Kern et al 2006</xref>, <xref ref-type="bibr" rid="ebd.REF.bale.2014">Bale &#x00026; Pfendner 2014</xref>].</p>
              </fn>
              <fn id="ebd.TF.1.4">
                <label>4. </label>
                <p>Note: Although sequencing of exons with a known founder variant(s) in individuals of certain ethnic backgrounds has been described in European populations, such an approach has not been fruitful in the US population, in which pathogenic variants can be found in any of the 118 exons of <italic toggle="yes">COL7A1.</italic> See <xref ref-type="sec" rid="ebd.Establishing_the_Diagnosis">Establishing the Diagnosis</xref>, <bold>Single-gene testing</bold>, Note.</p>
              </fn>
              <fn id="ebd.TF.1.5">
                <label>5. </label>
                <p>Testing that identifies exon or whole-gene deletions/duplications not detectable by sequence analysis of the coding and flanking intronic regions of genomic DNA. Included in the variety of methods that may be used are: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray (CMA) that includes this gene/chromosome segment.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Skin biopsy.</bold> Examination of a skin biopsy by transmission electron microscopy and/or immunofluorescent antibody/antigen mapping is one way to establish the diagnosis of DEB. However, sometimes, especially in milder forms of epidermolysis bullosa, indirect immunofluorescent studies are not sufficient to make the diagnosis because near-normal antigen levels are detected and no cleavage plane is observed. In such cases, electron microscopic examination of the skin biopsy must be performed to examine the basement membrane zone structures &#x02014; in particular, to determine the number and morphology of anchoring fibrils and the presence and morphology of hemidesmosomes, anchoring filaments, and keratin intermediate filaments.</p>
          <p>In DEB the blister forms below the basement membrane, which becomes attached to the blister roof, thus resulting in scarring when the blister heals.</p>
          <p>Note: Light microscopy is inadequate and unacceptable for the accurate diagnosis of epidermolysis bullosa.</p>
          <p>The biopsy should be taken from the leading edge of a fresh (&#x0003c;12 hours old) or a mechanically induced blister and should include some normal adjacent skin; older blisters undergo changes that may obscure the diagnostic morphology. Elliptic or shave excisions are often used. Although a punch biopsy can introduce confusing artifact, careful use of the punch can avoid loss of the epidermis.</p>
          <p>
            <bold>Findings on transmission electron microscopy (TEM)</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p><bold>All DEB.</bold> Splitting is observed below the lamina densa of the basement membrane of the epidermis.</p>
            </list-item>
            <list-item>
              <p><bold>Recessive DEB (RDEB), severe generalized type.</bold> Anchoring fibrils are markedly reduced or absent.</p>
            </list-item>
            <list-item>
              <p><bold>Dominant DEB (DDEB)</bold> and <bold>RDEB-other</bold></p>
              <list list-type="bullet">
                <list-item>
                  <p>Anchoring fibrils may appear reduced in number and show altered morphology.</p>
                </list-item>
                <list-item>
                  <p>Intracellular retention of collagen VII can be observed in some individuals.</p>
                </list-item>
                <list-item>
                  <p>Collagen VII may be retained intracellularly within the basal keratinocytes instead of being transported to the basement membrane zone in some individuals who have transient blistering in the newborn period.</p>
                </list-item>
              </list>
            </list-item>
          </list>
          <p>
            <bold>Findings on immunofluorescent antibody/antigen mapping</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Staining of collagen VII using antibodies is diminished or absent. (In mild DEB, staining for collagen VII may appear normal, but cleavage planes in the form of vesicles or microvesicles can be observed below the lamina densa and below the collagen VII staining.)</p>
            </list-item>
            <list-item>
              <p>Normal staining for other antigens (e.g., laminin 332, collagen XVII, plectin, &#x003b1;6&#x003b2;4 integrin, and keratins 5 and 14) confirms the diagnosis of DEB.</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec id="ebd.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="ebd.Clinical_Description">
          <title>Clinical Description</title>
          <p>Before the molecular basis of dystrophic epidermolysis bullosa (DEB) was understood, types and subtypes were identified based primarily on clinical features, mode of inheritance, and the presence or absence of collagen VII and anchoring fibrils detected on skin biopsy. The current classification system is based on inheritance pattern (autosomal dominant DEB versus autosomal recessive DEB) and is further stratified by collagen VII staining and the specific <italic toggle="yes">COL7A1</italic> pathogenic variant that is identified in a given affected individual (see <xref ref-type="sec" rid="ebd.Nomenclature">Nomenclature</xref>) [<xref ref-type="bibr" rid="ebd.REF.fine.2014.1103">Fine et al 2014</xref>]. For the purposes of this <italic toggle="yes">GeneReview</italic> the terms recessive DEB severe generalized (RDEB-sev gen), recessive DEB generalized other (RDEB-O) (which includes several further subtypes), and dominant DEB (DDEB) (which also includes further subtypes) have been retained and are discussed below.</p>
          <sec id="ebd.Recessive_DEB_Severe_Generalized_RDE">
            <title>Recessive DEB Severe Generalized (RDEB-sev gen)</title>
            <p>In this classic severe form of RDEB, blisters are present at birth or become apparent in the neonatal period. Medical consequences of RDEB-sev gen have been recently reviewed [<xref ref-type="bibr" rid="ebd.REF.fine.2009a.367">Fine &#x00026; Mellerio 2009a</xref>, <xref ref-type="bibr" rid="ebd.REF.fine.2009b.387">Fine &#x00026; Mellerio 2009b</xref>, <xref ref-type="bibr" rid="ebd.REF.murrell.2010">Murrell 2010</xref>].</p>
            <p>Blisters can affect the whole body including the oral mucosa, the esophageal mucosa, and the corneas as early as the newborn period. Secondary infection is common.</p>
            <p>Blistering continues throughout life with scarring that may lead to disfigurement. Scarring pseudosyndactyly of the hands and feet, a hallmark of this disorder, fuses the digits into "mitten" hands and feet with severe loss of function.</p>
            <p>Oral involvement may lead to fusion of the tongue to the floor of the mouth (ankyloglossia) and progressive diminution of the size of the oral cavity and mouth opening (microstomia) which, along with poor dental hygiene and caries, impairs food intake [<xref ref-type="bibr" rid="ebd.REF.serranomart_nez.2003.264">Serrano-Mart&#x000ed;nez et al 2003</xref>, <xref ref-type="bibr" rid="ebd.REF.de_benedittis.2004.128">De Benedittis et al 2004</xref>].</p>
            <p>Esophageal erosions and esophageal webs and strictures can cause severe dysphagia with resultant poor nutrition [<xref ref-type="bibr" rid="ebd.REF.castillo.2002.535">Castillo et al 2002</xref>, <xref ref-type="bibr" rid="ebd.REF.azizkhan.2006.55">Azizkhan et al 2006</xref>]. Rarely, affected individuals can have esophageal disease with few or no skin manifestations [<xref ref-type="bibr" rid="ebd.REF.zimmer.2002.220">Zimmer et al 2002</xref>].</p>
            <p>Anal erosions can cause severe constipation. Gastroesophageal reflux disease (GERD) is common.</p>
            <p>Corneal erosions can lead to scarring and loss of vision [<xref ref-type="bibr" rid="ebd.REF.matsumoto.2005.474">Matsumoto et al 2005</xref>].</p>
            <p>The lifetime risk of aggressive squamous cell carcinoma (SCC) is greater than 90% with significant metastatic potential [<xref ref-type="bibr" rid="ebd.REF.fine.2009.203">Fine et al 2009</xref>]. SCC usually appears in the third decade but can appear as early as the second decade [<xref ref-type="bibr" rid="ebd.REF.ayman.2002.436">Ayman et al 2002</xref>]. Affected individuals usually succumb to aggressive metastatic SCC.</p>
            <p>Many individuals develop large irregular brown patches that histologically comprise collections of nevus cells and are called EB nevi [<xref ref-type="bibr" rid="ebd.REF.lanschuetzer.2010.179">Lanschuetzer et al 2010</xref>]. No instances of melanoma arising in these nevi have been reported to date.</p>
            <p>Malnutrition caused by poor intake and an increased nutritional demand for tissue healing can result in growth retardation and failure to thrive in young children and absent or delayed puberty in older children.</p>
            <p>Anemia results from poor iron intake and the anemia of chronic disease with bone marrow suppression.</p>
            <p>Osteopenia and osteoporosis, often with vitamin D deficiency, result from poor nutrition, lack of exposure to adequate sunlight, and especially inactivity.</p>
            <p>Dilated cardiomyopathy has been reported in RDEB and can be fatal in some cases [<xref ref-type="bibr" rid="ebd.REF.laracorrales.2010.238">Lara-Corrales et al 2010</xref>].</p>
            <p>Urethral erosions, strictures, bladder dysfunction, and a variety of renal diseases can occur [<xref ref-type="bibr" rid="ebd.REF.fine.2004.651">Fine et al 2004</xref>].</p>
            <p>Severe stress to the patient and family because of the complications of this disorder and the chronic pain endured by the most affected individuals often result in decreased quality of life and psychosocial disorders including anxiety, depression, and drug dependence and abuse in older persons [<xref ref-type="bibr" rid="ebd.REF.frew.2010.185">Frew &#x00026; Murrell 2010</xref>].</p>
          </sec>
          <sec id="ebd.Recessive_DEB_Generalized_Other_RDEB">
            <title>Recessive DEB Generalized Other (RDEB-O)</title>
            <p>Multiple clinical phenotypes make up the spectrum of RDEB, many of which are not severe. The phenotype may be mild, with mild blistering localized to hands, feet, knees, and elbows and dystrophic nails, or relatively more widespread including flexural areas and trunk, but without the severe, mutilating scarring seen in RDEB-sev gen.</p>
            <p>In the less common variants there are distinct features:</p>
            <list list-type="bullet">
              <list-item>
                <p><bold>RDEB inversa.</bold> Blistering and skin atrophy occurs on the trunk, neck, thighs, and legs while no changes are observed on the hands, feet, elbows, or knees. Otherwise, the phenotype resembles DEB types with blistering and resulting scarring. Blisters of the hands and feet may be present in infancy.</p>
              </list-item>
              <list-item>
                <p><bold>RDEB pretibial and pruriginosa</bold> often affect the shins<bold>.</bold> Pretibial blisters develop into prurigo-like hyperkeratotic lesions. The lesions occur predominantly on the pretibial areas, sparing the knees and other parts of the skin. Other findings include nail dystrophy, albopapuloid skin lesions, and hypertrophic scars without pretibial predominance.</p>
              </list-item>
              <list-item>
                <p><bold>RDEB generalized intermediate (RDEB-gen intermediate)</bold> exhibits wide-spread blistering with scarring, milia, and nevi. Pseudosyndactyly may occur along with oral lesions and damaged or absent nails. Growth retardation is possible but not as severe as with RDEB sev gen. Squamous cell carcinoma also develops in some affected individuals.</p>
              </list-item>
              <list-item>
                <p><bold>RDEB localized</bold> exhibits blistering with scarring which may be severe but is localized to the hands and feet. Other sites are not affected. The nails are often absent. Growth retardation and systemic illness are also absent. Squamous cell carcinoma has not been reported in individuals who have this subtype.</p>
              </list-item>
              <list-item>
                <p><bold>RDEB centripetalis (RDEB-CE)</bold> is apparent at birth and involves the hands, feet, and pretibial areas only. Nails are absent. Growth retardation and systemic illness have not been reported. Squamous cell carcinoma has not been reported in individuals with this subtype.</p>
              </list-item>
              <list-item>
                <p><bold>Bullous dermolysis of the newborn</bold> often has only transient blistering limited to the newborn period [<xref ref-type="bibr" rid="ebd.REF.fassihi.2005.1058">Fassihi et al 2005</xref>].</p>
              </list-item>
            </list>
          </sec>
          <sec id="ebd.Dominant_DEB_DDEB">
            <title>Dominant DEB (DDEB)</title>
            <p>In this milder form of DEB, blistering is often limited to the hands, feet, knees, and elbows. Blistering may be relatively benign but nonetheless heals with scarring. Dystrophic nails, especially toenails, are common and loss of nails may occur. In the mildest forms, dystrophic nails may be the only characteristic noted [<xref ref-type="bibr" rid="ebd.REF.dharma.2001.93">Dharma et al 2001</xref>, <xref ref-type="bibr" rid="ebd.REF.satomatsumura.2002.269">Sato-Matsumura et al 2002</xref>, <xref ref-type="bibr" rid="ebd.REF.tosti.2003.456">Tosti et al 2003</xref>]. Blistering in DDEB often improves somewhat with age, possibly as a result of reduced physical activity. The subtypes of DDEB resemble those of RDEB but may present with milder manifestations.</p>
            <list list-type="bullet">
              <list-item>
                <p><bold>DDEB generalized (DDEB-gen)</bold> is a milder form of EB where a single pathogenic variant in <italic toggle="yes">COL7A1</italic> results in a milder blistering disease affecting most sites of friction in infancy but which often resolves to less severe disease in adulthood. Blisters form with scarring and the nails are often absent. Other systems are generally unaffected and growth retardation and squamous cell carcinoma are rarely reported.</p>
              </list-item>
              <list-item>
                <p><bold>DDEB pretibial</bold> represents the same phenotype as RDEB pretibial (see above); however, heterozygous pathogenic variants in <italic toggle="yes">COL7A1</italic> lead to an autosomal dominant pattern of inheritance.</p>
              </list-item>
              <list-item>
                <p><bold>DDEB pruriginosa</bold> represents the same phenotype as RDEB pruriginosa; however, heterozygous pathogenic variants in <italic toggle="yes">COL7A1</italic> lead to an autosomal dominant pattern of inheritance.</p>
              </list-item>
              <list-item>
                <p><bold>DDEB localized nails only</bold> affects the nails, which are dystrophic and fragile. No skin findings are identified.</p>
              </list-item>
            </list>
          </sec>
        </sec>
        <sec id="ebd.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>
            <bold>Recessive DEB (RDEB)</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p><bold>The severest forms</bold> are caused by biallelic pathogenic variants that result in either null or out-of-frame variants from insertions/deletions, single-base changes, and splice junction [<xref ref-type="bibr" rid="ebd.REF.mellerio.1999a.984">Mellerio et al 1999a</xref>, <xref ref-type="bibr" rid="ebd.REF.gardella.2002a.1456">Gardella et al 2002a</xref>, <xref ref-type="bibr" rid="ebd.REF.gardella.2002b.450">Gardella et al 2002b</xref>, <xref ref-type="bibr" rid="ebd.REF.mallipeddi.2003.810">Mallipeddi et al 2003</xref>]. The severity may be related to the position of the stop codon [<xref ref-type="bibr" rid="ebd.REF.tamai.1999.991">Tamai et al 1999</xref>]; however, the presence of some functional protein appears to be the most important factor in ameliorating the disease severity.</p>
            </list-item>
            <list-item>
              <p><bold>Moderately severe forms</bold> generally result from glycine substitution on one allele and a premature stop codon on the other allele; only a small amount of partially functional protein is made [<xref ref-type="bibr" rid="ebd.REF.murata.2000.477">Murata et al 2000</xref>, <xref ref-type="bibr" rid="ebd.REF.dharma.2001.93">Dharma et al 2001</xref>, <xref ref-type="bibr" rid="ebd.REF.varki.2007.181">Varki et al 2007</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Less severe forms</bold> generally result from other (non-gycine) amino acid substitutions and splice junction variants; there is wide phenotypic variability and range of pathogenic variants (&#x0003e;700 reported in the literature) [<xref ref-type="bibr" rid="ebd.REF.ashton.1999.232">Ashton et al 1999</xref>, <xref ref-type="bibr" rid="ebd.REF.mellerio.1999b.22">Mellerio et al 1999b</xref>, <xref ref-type="bibr" rid="ebd.REF.whittock.1999.673">Whittock et al 1999</xref>, <xref ref-type="bibr" rid="ebd.REF.gardella.2002a.1456">Gardella et al 2002a</xref>, <xref ref-type="bibr" rid="ebd.REF.murata.2004.442">Murata et al 2004</xref>, <xref ref-type="bibr" rid="ebd.REF.sawamura.2005.543">Sawamura et al 2005</xref>, <xref ref-type="bibr" rid="ebd.REF.varki.2007.181">Varki et al 2007</xref>].</p>
            </list-item>
          </list>
          <p><bold>Dominant DEB (DDEB).</bold> Most DDEB results from dominant-negative amino acid substitutions of glycine in the collagenous triple helical domain of collagen VII, although a few splice junction and other amino acid substitutions have been reported. Phenotypes may show intra- and interfamilial variability with the same pathogenic variant [<xref ref-type="bibr" rid="ebd.REF.murata.2000.477">Murata et al 2000</xref>, <xref ref-type="bibr" rid="ebd.REF.vaccaro.2000.436">Vaccaro et al 2000</xref>, <xref ref-type="bibr" rid="ebd.REF.mallipeddi.2003.810">Mallipeddi et al 2003</xref>, <xref ref-type="bibr" rid="ebd.REF.nakamura.2004.195">Nakamura et al 2004</xref>, <xref ref-type="bibr" rid="ebd.REF.wessagowit.2005.863">Wessagowit et al 2005</xref>].</p>
        </sec>
        <sec id="ebd.Penetrance">
          <title>Penetrance</title>
          <p>Until recently, pathogenic variants in <italic toggle="yes">COL7A1</italic> were considered to be 100% penetrant when family members were evaluated for mild features of the disease. However, in several families, an individual with DDEB and a known <italic toggle="yes">COL7A1</italic> pathogenic variant had relatives with the same variant that had no signs of the disease. Penetrance therefore appears to be less than 100%, at least in DDEB [<xref ref-type="bibr" rid="ebd.REF.almaani.2011.262">Almaani et al 2011</xref>; Pfendner, unpublished observation].</p>
        </sec>
        <sec id="ebd.Anticipation">
          <title>Anticipation</title>
          <p>Anticipation is not a feature of DEB.</p>
        </sec>
        <sec id="ebd.Nomenclature">
          <title>Nomenclature</title>
          <p>Recessive DEB, severe generalized (RDEB-sev gen) was originally called Hallopeau-Siemens type (RDEB-HS).</p>
          <p>Recessive DEB, generalized intermediate (RDEB gen intermed) and localized (RDEB -loc) were originally called non-Hallopeau-Siemens type (RDEB-non-HS).</p>
          <p>The nomenclature for DEB has changed four times in the last fifteen years. The most recent classification system, referred to as the &#x0201c;onion skin&#x0201d; terminology, arose from the most recent international consensus meeting, the recommendations of which were published in June 2014 [<xref ref-type="bibr" rid="ebd.REF.fine.2014.1103">Fine et al 2014</xref>]. This classification system starts by dividing DEB into the inheritance pattern followed by a histologic description of collagen VII staining, and then the specific <italic toggle="yes">COL7A1</italic> pathogenic variant that has been described in the affected individual (see <xref ref-type="table" rid="ebd.T.comparison_of_2008_nomenclature_wi">Table 2</xref>).</p>
          <p>For information on the newest nomenclature recommendations that pertain to epidermolysis bullosa simplex and junctional epidermolysis bullosa, see <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="ebd-Table3.pdf" content-type="local-data">Table 3</inline-supplementary-material> (pdf).</p>
          <table-wrap id="ebd.T.comparison_of_2008_nomenclature_wi" orientation="portrait" position="anchor">
            <label>Table 2. </label>
            <caption>
              <p>Comparison of 2008 Nomenclature with Proposed &#x0201c;Onion Skin&#x0201d; Terminology &#x02013; Representative Examples</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_ebd.T.comparison_of_2008_nomenclature_wi_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Old Name&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_ebd.T.comparison_of_2008_nomenclature_wi_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">2014 Nomenclature</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_ebd.T.comparison_of_2008_nomenclature_wi_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">RDEB, severe generalized</td>
                  <td headers="hd_h_ebd.T.comparison_of_2008_nomenclature_wi_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">RDEB generalized severe, collagen VII absent, <italic toggle="yes">COL7A1</italic> pathogenic variants (specify type)</td>
                </tr>
                <tr>
                  <td headers="hd_h_ebd.T.comparison_of_2008_nomenclature_wi_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">RDEB, generalized other</td>
                  <td headers="hd_h_ebd.T.comparison_of_2008_nomenclature_wi_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">RDEB generalized intermediate, collagen VII reduced staining, <italic toggle="yes">COL7A1</italic> pathogenic variants (specify type)</td>
                </tr>
                <tr>
                  <td headers="hd_h_ebd.T.comparison_of_2008_nomenclature_wi_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">RDEB-BDN</td>
                  <td headers="hd_h_ebd.T.comparison_of_2008_nomenclature_wi_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">RDEB-BDN, granular intraepidermal collagen VII staining, <italic toggle="yes">COL7A1</italic> pathogenic variants (specify)</td>
                </tr>
                <tr>
                  <td headers="hd_h_ebd.T.comparison_of_2008_nomenclature_wi_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">DDEB generalized</td>
                  <td headers="hd_h_ebd.T.comparison_of_2008_nomenclature_wi_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">DDEB generalized, normal collagen VII staining, <italic toggle="yes">COL7A1</italic> pathogenic variant (specify)</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>BDN = bullous dermolysis of newborn</p>
              </fn>
              <fn>
                <p>DDEB = dominant dystrophic epidermolysis bullosa</p>
              </fn>
              <fn>
                <p>RDEB = recessive dystrophic epidermolysis bullosa</p>
              </fn>
              <fn id="ebd.TF.2.1">
                <label>1. </label>
                <p>Per 2008 recommendations</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
        <sec id="ebd.Prevalence">
          <title>Prevalence</title>
          <p>According to the National EB Registry, the incidence of all types of DEB is 6.5 per million live births in the US population.</p>
          <list list-type="bullet">
            <list-item>
              <p>Mild forms of DDEB are estimated at 2.9 per million but may be under-represented.</p>
            </list-item>
            <list-item>
              <p>RDEB incidence is 0.4-0.6 per million live births.</p>
            </list-item>
          </list>
          <p>The carrier frequency of RDEB in the US population has been calculated as one in 370 [<xref ref-type="bibr" rid="ebd.REF.pfendner.2001.483">Pfendner et al 2001</xref>].</p>
        </sec>
      </sec>
      <sec id="ebd.Genetically_Related_Allelic_Disorder">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No phenotypes other than those discussed in this <italic toggle="yes">GeneReview</italic> are known to be associated with mutation of <italic toggle="yes">COL7A1</italic>.</p>
      </sec>
      <sec id="ebd.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The four major types of epidermolysis bullosa (EB) syndrome, caused by pathogenic variants in 20 different genes, are EB simplex (EBS), junctional EB (JEB), dystrophic EB (DEB), and Kindler syndrome. While agreement exists as to diagnostic criteria for some types of epidermolysis bullosa, the validity of rarer subtypes and their diagnostic criteria are disputed. See <xref ref-type="bibr" rid="ebd.REF.murrell.2010">Murrell [2010]</xref> for excellent clinical reviews and <xref ref-type="bibr" rid="ebd.REF.fine.2014.1103">Fine et al [2014]</xref> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.sciencedirect.com/science/article/pii/S0190962214010408">full text</ext-link>; note especially Figure 1) for the revised classification system.</p>
        <p>The four major types of EB share fragility of the skin, manifested by blistering and/or erosions with little or no trauma. A positive Nikolsky sign (blistering of uninvolved skin after rubbing) is common to all types of EB. No clinical findings are specific to a given type; thus, establishing the EB type requires further laboratory evaluation. Molecular genetic testing may be used to establish a diagnosis (see <xref ref-type="sec" rid="ebd.Establishing_the_Diagnosis">Establishing the Diagnosis</xref>). Alternatively, a fresh skin biopsy from a newly induced blister that is stained by indirect immunofluorescence for critical basement membrane protein components can be performed. The diagnosis is established by determining the cleavage plane and the presence/absence and distribution of these protein components. Electron microscopy is also diagnostic and often more useful in milder forms of EB.</p>
        <p>Clinical examination is useful in determining the extent of blistering, the presence of oral and other mucous membrane lesions, and the presence and extent of scarring.</p>
        <p>Limitations of the clinical findings in establishing the type of EB include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>In young children and neonates, the extent and severity of blistering and scarring may not be established or significant enough to allow identification of EB type.</p>
          </list-item>
          <list-item>
            <p>Mucosal and nail involvement and the presence or absence of milia may not be helpful discriminators.</p>
          </list-item>
          <list-item>
            <p>Post-inflammatory changes such as those seen in EBS, Dowling-Meara type (EBS-DM) are often mistaken for scarring or mottled pigmentation.</p>
          </list-item>
          <list-item>
            <p>Scarring can occur in EB simplex and junctional EB as a result of infection of erosions or scratching, which further damages the exposed surface.</p>
          </list-item>
          <list-item>
            <p>Congenital absence of the skin can be seen in any of the three major types of EB (i.e., EBS, JEB, DEB) and is not a discriminating diagnostic feature.</p>
          </list-item>
        </list>
        <p>Clinical findings that tend to be specific for a single type of EB include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Esophageal strictures and nail involvement suggest DEB.</p>
          </list-item>
          <list-item>
            <p>Tooth enamel involvement suggests JEB.</p>
          </list-item>
          <list-item>
            <p>Scarring and milia of the hands and feet in milder cases suggests DEB rather than EBS.</p>
          </list-item>
          <list-item>
            <p>Pseudosyndactyly (mitten deformities) caused by scarring of the hands and feet in older children and adults usually suggests RDEB.</p>
          </list-item>
        </list>
        <p><related-object link-type="booklink" source-id="gene" document-id="ebs" document-type="chapter"><bold>Epidermolysis bullosa simplex</bold></related-object>
<bold>(EBS)</bold> is characterized by fragility of the skin (and mucosal epithelia in some cases) that results in nonscarring blisters caused by little or no trauma. The current classification of epidermolysis bullosa (EB) includes two major types and 12 minor subtypes of EBS; all share the common feature of blistering above the dermal-epidermal junction at the ultrastructural level. The four most common subtypes of EBS are:</p>
        <list list-type="bullet">
          <list-item>
            <p>EBS, localized (EBS-loc; previously known as Weber-Cockayne type);</p>
          </list-item>
          <list-item>
            <p>EBS, Dowling-Meara type (EBS-DM);</p>
          </list-item>
          <list-item>
            <p>EBS, other generalized (EBS, gen-nonDM; previously known as Koebner type);</p>
          </list-item>
          <list-item>
            <p>EBS-with mottled pigmentation (EBS-MP).</p>
          </list-item>
        </list>
        <p>The phenotypes for these subtypes range from relatively mild blistering of the hands and feet to more generalized blistering, which can be fatal. In EBS-loc, blisters are rarely present or minimal at birth and may occur on the knees and shins with crawling or on the feet at approximately age18 months; some individuals manifest the disease in adolescence or early adulthood. Blisters are usually confined to the hands and feet, but can occur anywhere if trauma is significant.</p>
        <p>In EBS, gen-non DM, blisters may be present at birth or develop within the first few months of life. Involvement is more widespread than in EBS-loc, but generally milder than in EBS-DM.</p>
        <p>In EBS-MP, skin fragility is evident at birth and clinically indistinguishable from EBS-DM; over time, progressive brown pigmentation interspersed with hypopigmented spots develops on the trunk and extremities, with the pigmentation disappearing in adult life. Focal palmar and plantar hyperkeratoses may occur.</p>
        <p>In EBS-DM, onset is usually at birth; severity varies greatly, both within and among families. Widespread and severe blistering and/or multiple grouped clumps of small blisters are typical and hemorrhagic blisters are common. Improvement occurs during mid- to late childhood. EBS-DM appears to improve with warmth in some individuals. Progressive hyperkeratosis of the palms and soles begins in childhood and may be the major complaint of affected individuals in adult life. Nail dystrophy and milia are common. Both hyper- and hypopigmentation can occur. Mucosal involvement in EBS-DM may interfere with feeding. Blistering can be severe enough to result in neonatal or infant death.</p>
        <p>The four most common forms of EBS are caused by mutation of either <italic toggle="yes">KRT5</italic> or <italic toggle="yes">KRT14</italic>. Molecular genetic testing of <italic toggle="yes">KRT5</italic> and <italic toggle="yes">KRT14</italic> detects pathogenic variants in approximately 75% of individuals with biopsy-diagnosed EBS-loc, EBS-DM, and EBS-gen-nonDM, and in 90%-95% of those with EBS-MP.</p>
        <p>Rarer subtypes of EBS include:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>EBS, autosomal recessive (EBS-AR).</bold> Patients tend to have more severe disease. Homozygous pathogenic variants in keratin 14 and plectin have been described.</p>
          </list-item>
          <list-item>
            <p><bold>EBS with muscular dystrophy (EBS-MD)</bold> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/226670">OMIM</ext-link>). Some individuals with EB caused by PLEC1 pathogenic variants develop muscular dystrophy either in childhood or later in life [<xref ref-type="bibr" rid="ebd.REF.charlesworth.2003.1344">Charlesworth et al 2003</xref>, <xref ref-type="bibr" rid="ebd.REF.kossharnes.2004.124">Koss-Harnes et al 2004</xref>, <xref ref-type="bibr" rid="ebd.REF.schara.2004.218">Schara et al 2004</xref>, <xref ref-type="bibr" rid="ebd.REF.pfendner.2005.241">Pfendner et al 2005</xref>]. Inheritance in this form of EBS is autosomal recessive.</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="eb-pa" document-type="chapter"><bold>EBS with pyloric atresia</bold></related-object>
<bold>(EBS-PA).</bold> In several US and Japanese families, EB-PA is associated with premature termination variants in PLEC1 [<xref ref-type="bibr" rid="ebd.REF.nakamura.2004.195">Nakamura et al 2004</xref>, <xref ref-type="bibr" rid="ebd.REF.pfendner.2005.111">Pfendner &#x00026; Uitto 2005</xref>]. Only lethal EBS-PA cases have been described in the literature.</p>
          </list-item>
        </list>
        <p><related-object link-type="booklink" source-id="gene" document-id="ebj" document-type="chapter"><bold>Junctional EB</bold></related-object>
<bold>(JEB)</bold> is characterized by fragility of the skin and mucous membranes, manifest by blistering with little or no trauma. Blistering may be severe and granulation tissue can form on the skin around the oral and nasal cavities, fingers, and toes, and internally around the upper airway. Blisters generally heal with no significant scarring. Broad classification of JEB includes Herlitz JEB (aka lethal) and non-Herlitz JEB (aka non-lethal). In Herlitz JEB, the classic severe form of JEB, blisters are present at birth or become apparent in the neonatal period. Congenital malformations of the urinary tract and bladder may also occur. In non-Herlitz JEB, the phenotype may be mild with blistering localized to hands, feet, knees, and elbows with or without renal or ureteral involvement. Some individuals never blister after the newborn period. Additional features shared by JEB and the other major forms of epidermolysis bullosa (EB) include congenital localized absence of skin (aplasia cutis congenita), milia, nail dystrophy, scarring alopecia, hypotrichosis, pseudosyndactyly, and other contractures. The four genes in which pathogenic variants are known to cause JEB are <italic toggle="yes">LAMB3</italic> (70% of all JEB), <italic toggle="yes">COL17A1</italic> (12%), <italic toggle="yes">LAMC2</italic> (9%), and <italic toggle="yes">LAMA3</italic> (9%).</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="kindler" document-type="chapter"><bold>Kindler syndrome</bold></related-object><bold>.</bold> The classification of <xref ref-type="bibr" rid="ebd.REF.fine.2014.1103">Fine et al [2014]</xref> identifies Kindler syndrome as a major type in the EB or bullous disorders. It is characterized by multiple cleavage planes; specifically epidermal, lamina lucida, and sub lamina densa. The presence of multiple cleavage planes is a characteristic that is unique to the mechanobullous disorders. The phenotype can be severe at birth but resolves later in life and includes poikiloderma and photosensitivity. Pathogenic variants in <italic toggle="yes">FERMT1</italic> (Kindlin 1) have been demonstrated; inheritance is autosomal recessive [<xref ref-type="bibr" rid="ebd.REF.jobard.2003.925">Jobard et al 2003</xref>, <xref ref-type="bibr" rid="ebd.REF.siegel.2003.174">Siegel et al 2003</xref>].</p>
      </sec>
      <sec id="ebd.Management">
        <title>Management</title>
        <sec id="ebd.Evaluations_Following_Initial_Diagno">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with dystrophic epidermolysis bullosa (DEB), evaluation of the sites of blister formation including oral and esophageal blisters and erosions is recommended. Clinical genetics consultation may also be considered.</p>
        </sec>
        <sec id="ebd.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p><bold>Skin.</bold> New blisters should be lanced and drained to prevent further spread from fluid pressure [<xref ref-type="bibr" rid="ebd.REF.pope.2012.904">Pope et al 2012</xref>].</p>
          <p>Families must decide which of the many correct and effective methods of bandaging works best for them. In most cases, dressings for blisters involve three layers:</p>
          <list list-type="bullet">
            <list-item>
              <p>A primary non-adherent dressing that does not strip the top layers of the epidermis. Tolerance to different primary layers varies. Primary layers may include any the following:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Ordinary Band-Aids<sup>&#x000ae;</sup></p>
                </list-item>
                <list-item>
                  <p>Dressings impregnated with an emollient such as petrolatum or topical antiseptic (e.g., Vaseline<sup>&#x000ae;</sup> gauze, Adaptic<sup>&#x000ae;</sup>, Xeroform<sup>&#x000ae;</sup>)</p>
                </list-item>
                <list-item>
                  <p>Non-stick products (e.g., Telfa<sup>&#x000ae;</sup> or N-terface<sup>&#x000ae;</sup>)</p>
                </list-item>
                <list-item>
                  <p>Silicone-based products without adhesive (e.g., Mepitel<sup>&#x000ae;</sup> or Mepilex<sup>&#x000ae;</sup>)</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>A secondary layer providing stability for the primary layer and adding padding to allow more activity. Rolls of gauze (e.g., Conform<sup>&#x000ae;</sup>, Kerlix<sup>&#x000ae;,</sup>) are commonly used.</p>
            </list-item>
            <list-item>
              <p>A tertiary layer (usually with some elastic properties) that ensures the integrity of the dressing (e.g., Tubifast<sup>&#x000ae;</sup>, Coban<sup>&#x000ae;</sup> or elasticized tube-gauze of varying diameters such as Band Net<sup>&#x000ae;</sup>)</p>
            </list-item>
          </list>
          <p>Various lubricants and antimicrobial agents such as topical antibiotics, silver, or honey are often added to the contact layer to prevent and treat infection and promote healing.</p>
          <p>In infants and children with RDEB with more severe involvement, failure to thrive may be a problem, requiring additional nutritional support including a feeding gastrostomy when necessary to assure adequate caloric intake [<xref ref-type="bibr" rid="ebd.REF.haynes.1996.872">Haynes et al 1996</xref>, <xref ref-type="bibr" rid="ebd.REF.stehr.2008.349">Stehr et al 2008</xref>]. Esophageal strictures and webs can be dilated repeatedly to improve swallowing [<xref ref-type="bibr" rid="ebd.REF.castillo.2002.535">Castillo et al 2002</xref>, <xref ref-type="bibr" rid="ebd.REF.kay.2002.515">Kay &#x00026; Wyllie 2002</xref>, <xref ref-type="bibr" rid="ebd.REF.azizkhan.2006.55">Azizkhan et al 2006</xref>].</p>
          <p><bold>Other.</bold> Fluid and electrolyte problems, which can be significant and even life-threatening in the neonatal period and in infants with widespread disease, require careful management.</p>
          <p>Anemia is a chronic problem with RDEB and can be treated with oral or intravenous iron infusions and red blood cell transfusions.</p>
          <p>Other nutritional deficiencies must also be addressed:</p>
          <list list-type="bullet">
            <list-item>
              <p>Calcium and vitamin D supplementation for osteopenia and osteoporosis</p>
            </list-item>
            <list-item>
              <p>Selenium and carnitine replacement to help prevent dilated cardiomyopathy</p>
            </list-item>
            <list-item>
              <p>Zinc replacement to enhance wound healing</p>
            </list-item>
          </list>
          <p>Good prophylactic dental care is essential to insure the ability to eat and to allow for adequate caloric intake [<xref ref-type="bibr" rid="ebd.REF.harris.2001.438">Harris et al 2001</xref>].</p>
          <p>Some children have delays or difficulty walking because of blistering and hyperkeratosis. Appropriate footwear and physical therapy are essential to preserve ambulation.</p>
          <p>Occupational therapy may be helpful in preventing progressive hand contractures. Splinting of the hands can be problematic because of skin fragility. Surgical release of fingers by several methods has been described; it often needs to be performed repeatedly [<xref ref-type="bibr" rid="ebd.REF.mar_nbertol_n.1999.555">Mar&#x000ed;n-Bertol&#x000ed;n et al 1999</xref>, <xref ref-type="bibr" rid="ebd.REF.glicenstein.2000.637">Glicenstein et al 2000</xref>].</p>
          <p>Psychosocial support including social services and psychological counseling is essential.</p>
        </sec>
        <sec id="ebd.Prevention_of_Primary_Manifestations">
          <title>Prevention of Primary Manifestations</title>
          <p>Age-appropriate play involving activities that cause minimal trauma to the skin is encouraged.</p>
          <p>Dressings and padding are needed to protect bony prominences from blister-inducing impact.</p>
          <p>If a fetus is known to be affected with any form of DEB, cesarean delivery may reduce trauma to the skin during delivery.</p>
        </sec>
        <sec id="ebd.Prevention_of_Secondary_Complication">
          <title>Prevention of Secondary Complications</title>
          <p>The most common secondary complication is infection. In addition to wound care, treatment of chronic infection of wounds is a challenge. Many affected individuals become infected with resistant bacteria, most often methicillin-resistant <italic toggle="yes">Staphylococcus</italic>
<italic toggle="yes">aureus</italic> (MRSA) and <italic toggle="yes">Pseudomonas</italic>
<italic toggle="yes">aeruginosa</italic>. Both antibiotics and antiseptics need to be employed.</p>
        </sec>
        <sec id="ebd.Surveillance">
          <title>Surveillance</title>
          <p>Because the lifetime risk of metastatic squamous cell carcinoma is greater than 90% in individuals with RDEB, surveillance in the second decade of life for wounds that do not heal, have exuberant scar tissue, or otherwise look abnormal is essential. Frequent biopsies of suspicious lesions may be necessary followed by local excision.</p>
          <p>Screening for anemia should be routine with complete blood counts and possibly measurement of serum iron concentration in order to provide iron supplementation when necessary.</p>
          <p>Screening for zinc deficiency by measurement of serum zinc concentration should be routine in order to provide zinc supplementation when necessary to enhance wound healing.</p>
          <p>Screening for predisposition to dilated cardiomyopathy secondary to selenium deficiency and carnitine deficiency is possible by measurement of serum concentrations of selenium and carnitine. Screening for dilated cardiomyopathy by transthoracic echocardiogram is also useful [<xref ref-type="bibr" rid="ebd.REF.sidwell.2000.59">Sidwell et al 2000</xref>]. No guidelines regarding the age at which such screening should begin have been established.</p>
          <p>Screening with bone mineral density scanning may pick up early osteopenia and/or osteoporosis. No guidelines have been established regarding the age at which this should begin.</p>
        </sec>
        <sec id="ebd.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>Poorly fitting or coarse-textured clothing and footwear should be avoided as they can cause trauma.</p>
          <p>In general, activities that traumatize the skin (e.g., hiking, mountain biking, contact sports) should be avoided; affected individuals who are committed to participation in such activities should be encouraged to devise ways of protecting the skin.</p>
          <p>Most persons with DEB cannot use ordinary medical tape or Band-Aids<sup>&#x000ae;</sup>.</p>
        </sec>
        <sec id="ebd.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>Evaluating an at-risk newborn for evidence of blistering is appropriate so that trauma to the skin can be avoided as much as possible.</p>
          <p>See <xref ref-type="sec" rid="ebd.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="ebd.Pregnancy_Management">
          <title>Pregnancy Management</title>
          <p>Cesarean section is often recommended to avoid vaginal delivery in a fetus at risk.</p>
        </sec>
        <sec id="ebd.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>The use of mouse models for EB has enhanced molecular therapies for the treatment of EB by mimicking the EB phenotypes and facilitating testing of a number of therapeutic approaches including the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Gene replacement therapy [<xref ref-type="bibr" rid="ebd.REF.ito.2009.2508">Ito et al 2009</xref>], including inducible expression of the target gene under the control of a keratinocyte specific promoter [<xref ref-type="bibr" rid="ebd.REF.adairkirk.2012.e45546">Adair-Kirk et al 2012</xref>]</p>
            </list-item>
            <list-item>
              <p>Stem cell replacement therapy [<xref ref-type="bibr" rid="ebd.REF.chino.2008.803">Chino et al 2008</xref>, <xref ref-type="bibr" rid="ebd.REF.tolar.2009.1167">Tolar et al 2009</xref>, <xref ref-type="bibr" rid="ebd.REF.fujita.2010.14345">Fujita et al 2010</xref>]</p>
            </list-item>
            <list-item>
              <p>Generation of three-dimensional skin replacement using pluripotent stem cells [<xref ref-type="bibr" rid="ebd.REF.itoh.2013.e77673">Itoh et al 2013</xref>]</p>
            </list-item>
            <list-item>
              <p>Allogenic transplantation of fibroblasts [<xref ref-type="bibr" rid="ebd.REF.fritsch.2008.1669">Fritsch et al 2008</xref>]</p>
            </list-item>
            <list-item>
              <p>Infusions of type VII collagen protein [<xref ref-type="bibr" rid="ebd.REF.remington.2009.26">Remington et al 2009</xref>, <xref ref-type="bibr" rid="ebd.REF.hovnanian.2013.1719">Hovnanian 2013</xref>, <xref ref-type="bibr" rid="ebd.REF.woodley.2013.1910">Woodley et al 2013</xref>]</p>
            </list-item>
            <list-item>
              <p>Topical treatment with recombinant collagen VII [<xref ref-type="bibr" rid="ebd.REF.wang.2013.1335">Wang et al 2013</xref>]</p>
            </list-item>
          </list>
          <p>In addition, older approaches involving the use of viral vectors to transfer functional genes to cultured cells for transplant into humans are still being explored [<xref ref-type="bibr" rid="ebd.REF.siprashvili.2010.1299">Siprashvili et al 2010</xref>, <xref ref-type="bibr" rid="ebd.REF.titeux.2010.361">Titeux et al 2010</xref>, <xref ref-type="bibr" rid="ebd.REF.melo.2014.725">Melo et al 2014</xref>].</p>
          <list list-type="bullet">
            <list-item>
              <p>A new approach using engineered transcription activator-like effector nucleases (TALEN) for precise genome editing results in integration of the desired sequence in the targeted gene and in non-coding regions, reducing the risk of integration mutagenesis.</p>
            </list-item>
            <list-item>
              <p>TALENs were able to induce site-specific double-stranded DNA breaks (DSBs) leading to homology-directed repair (HDR) from an exogenous normal <italic toggle="yes">COL7A1</italic> donor template. This resulted in mutation correction in <italic toggle="yes">COL7A1</italic> in primary fibroblasts that were subsequently reprogrammed into inducible pluripotent stem cells and showed normal protein expression and deposition in an in vivo skin model [<xref ref-type="bibr" rid="ebd.REF.osborn.2013.1151">Osborn et al 2013</xref>].</p>
            </list-item>
          </list>
          <p>Human trials for the treatment of EB that have just begun include the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Use of naturally occurring gene revertant pluropotent cells transplanted into individuals with RDEB [<xref ref-type="bibr" rid="ebd.REF.tolar.2014.1246">Tolar et al 2014</xref>]</p>
            </list-item>
            <list-item>
              <p>Local grafting of skin cells in which the genetic pathogenic variants have been corrected for treatment of human JEB [<xref ref-type="bibr" rid="ebd.REF.de_luca.2009.19">De Luca et al 2009</xref>, <xref ref-type="bibr" rid="ebd.REF.de_rosa.2013.1">De Rosa et al 2013</xref>]</p>
            </list-item>
            <list-item>
              <p>Local grafting of revertant skin in the treatment of JEB [<xref ref-type="bibr" rid="ebd.REF.gosty_ski.2014.98">Gosty&#x00144;ski et al 2014</xref>]</p>
            </list-item>
            <list-item>
              <p>Cell transfer-based treatment for DEB [<xref ref-type="bibr" rid="ebd.REF.ortizurda.2003.251">Ortiz-Urda et al 2003</xref>; A Lane, Stanford University, personal communication]. One person with JEB has had cell transfer treatment on the legs. A large Stanford University trial for DEB has begun and one one affected individual is reported to be doing well six months after grafting [<xref ref-type="bibr" rid="ebd.REF.siprashvili.2014">Siprashvili et al 2014</xref>] (see <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov">ClinicalTrials.gov</ext-link>).</p>
            </list-item>
            <list-item>
              <p>Intradermal injections of large quantities of recombinant collagen 7 protein grown in vitro has shown efficacy in a murine model [<xref ref-type="bibr" rid="ebd.REF.remington.2009.26">Remington et al 2009</xref>
<xref ref-type="bibr" rid="ebd.REF.woodley.2013.1910">Woodley et al 2013</xref>]. Human clinical trials are likely to be under way in the near future.</p>
            </list-item>
            <list-item>
              <p>Intradermal injections of allogenic fibroblasts have reconstituted collagen 7 protein in the basement membrane. Although it appears that this &#x0201c;new&#x0201d; collagen 7 protein is identical to the mutated protein of the host, the increased quantities of collagen 7 seem to be clinically beneficial [<xref ref-type="bibr" rid="ebd.REF.wong.2008.2179">Wong et al 2008</xref>]. A recent trial in Australia showed that both fibroblasts and a non-fibroblast-containing vehicle improved healing in RDEB [<xref ref-type="bibr" rid="ebd.REF.venugopal.2013.898">Venugopal et al 2013</xref>].</p>
            </list-item>
            <list-item>
              <p>Bone marrow transplantation:</p>
              <list list-type="simple">
                <list-item>
                  <p>Systemic use of allogenic stem cells has been shown in a murine model to have a clinically beneficial effect on blistering [<xref ref-type="bibr" rid="ebd.REF.tolar.2009.1167">Tolar et al 2009</xref>]. Currently trials of bone marrow and/or umbilical-cord stem cell transplants, using either conventional myeloablative or reduced intensity conditioning, are underway in two centers in the USA. See <xref ref-type="bibr" rid="ebd.REF.wagner.2010.629">Wagner et al [2010]</xref> and search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov">ClinicalTrials.gov</ext-link> for details of the two EB trials at the University of Minnesota and Columbia University [<xref ref-type="bibr" rid="ebd.REF.tolar.2013.1214">Tolar &#x00026; Wagner 2013</xref>, <xref ref-type="bibr" rid="ebd.REF.liao.2014.303">Liao et al 2014</xref>].</p>
                </list-item>
                <list-item>
                  <p>Replacement of missing collagen 7 protein in RDEB has been accomplished using local injections of bone-marrow-derived mesenchymal stem cells. The clinical effect of healing of chronic wounds was noted in two patients; however, it lasted only four months [<xref ref-type="bibr" rid="ebd.REF.conget.2010.429">Conget et al 2010</xref>].</p>
                </list-item>
              </list>
            </list-item>
          </list>
          <p>Medical treatment of lesions suspicious for squamous cell carcinoma with agents such as topical imiquimod needs to be studied further.</p>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions.</p>
        </sec>
      </sec>
      <sec id="ebd.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="ebd.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Dystrophic epidermolysis bullosa (DEB) is inherited in an autosomal dominant or autosomal recessive manner.</p>
        </sec>
        <sec id="ebd.Risk_to_Family_Members__Autosomal_Do">
          <title>Risk to Family Members &#x02014; Autosomal Dominant Inheritance</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Approximately 70% of individuals diagnosed with dominant DEB (DDEB) are reported to have an affected parent and about 30% of probands may have the disorder as the result of a <italic toggle="yes">de novo</italic>
<italic toggle="yes">COL7A1</italic> pathogenic variant [<xref ref-type="bibr" rid="ebd.REF.wessagowit.2001.97">Wessagowit et al 2001</xref>, <xref ref-type="bibr" rid="ebd.REF.varki.2007.181">Varki et al 2007</xref>]; however, these numbers may not reflect the true proportion of <italic toggle="yes">de novo</italic> pathogenic variants because of bias of ascertainment.</p>
            </list-item>
            <list-item>
              <p>Maternal germline mosaicism has been reported [<xref ref-type="bibr" rid="ebd.REF.cserhalmifriedman.2001.1327">Cserhalmi-Friedman et al 2001</xref>].</p>
            </list-item>
            <list-item>
              <p>Recommendations for the evaluation of parents of a proband with an apparent <italic toggle="yes">de novo</italic> pathogenic variant include molecular genetic testing for the pathogenic variant found in the proband.</p>
            </list-item>
          </list>
          <p>Note: (1) Although 70% of individuals diagnosed with DDEB have an affected parent, the family history may appear to be negative because of failure to recognize the disorder in family members or reduced penetrance. (2) If the parent is the individual in whom mutation first occurred, s/he may have somatic mosaicism for the pathogenic variant and may be mildly/minimally affected.</p>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to the sibs of the proband depends on the genetic status of the proband's parents.</p>
            </list-item>
            <list-item>
              <p>If a parent of the proband is affected, the risk to the sibs is 50%.</p>
            </list-item>
            <list-item>
              <p>When the parents are clinically unaffected, the risk to the sibs of a proband appears to be low.</p>
            </list-item>
            <list-item>
              <p>If the pathogenic variant found in the proband cannot be detected in the leukocyte DNA of either parent, the risk to sibs is low (~1 in 10<sup>6</sup>) but greater than that of the general population because germline mosaicism has been reported [<xref ref-type="bibr" rid="ebd.REF.cserhalmifriedman.1999.143">Cserhalmi-Friedman et al 1999</xref>, <xref ref-type="bibr" rid="ebd.REF.cserhalmifriedman.2001.1327">Cserhalmi-Friedman et al 2001</xref>].</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Each child of an individual with DDEB has a 50% chance of inheriting the <italic toggle="yes">COL7A1</italic> pathogenic variant.</p>
          <p>
            <bold>Other family members of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to other family members depends on the status of the proband's parents.</p>
            </list-item>
            <list-item>
              <p>If a parent is affected, his or her family members are at risk.</p>
            </list-item>
          </list>
        </sec>
        <sec id="ebd.Risk_to_Family_Members__Autosomal_Re">
          <title>Risk to Family Members &#x02014; Autosomal Recessive Inheritance</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The parents of a child with recessive dystrophic epidermolysis bullosa (RDEB) are obligate heterozygotes (i.e., carriers of one <italic toggle="yes">COL7A1</italic> pathogenic variant).</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, each sib of an individual with RDEB whose parents are both carriers has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier.</p>
            </list-item>
            <list-item>
              <p>Once an at-risk sib is known to be unaffected, the risk of his/her being a carrier is 2/3.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> The offspring of an individual with RDEB are obligate heterozygotes (carriers) for a pathogenic variant in <italic toggle="yes">COL7A1</italic>.</p>
          <p><bold>Other family members of a proband.</bold> Each sib of the proband's parents is at a 50% risk of being a carrier of a <italic toggle="yes">COL7A1</italic> pathogenic variant.</p>
        </sec>
        <sec id="ebd.Carrier_Detection">
          <title>Carrier Detection</title>
          <p>Carrier testing for at-risk relatives requires prior identification of the <italic toggle="yes">COL7A1</italic> pathogenic variants in the family.</p>
        </sec>
        <sec id="ebd.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>See Management, <xref ref-type="sec" rid="ebd.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</xref> for information on evaluating a-risk relatives for the purpose of early diagnosis and treatment.</p>
          <p><bold>Considerations in families with an apparent <italic toggle="yes">de novo</italic> pathogenic variant.</bold> When neither parent of a proband with an autosomal dominant condition has clinical evidence of the disorder, it is likely that the proband has a <italic toggle="yes">de novo</italic> pathogenic variant. However, possible non-medical explanations including alternate paternity or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.</p>
          <p><bold>Determining the mode of inheritance in a simplex case (i.e., a single occurrence in a family).</bold> Molecular characterization of pathogenic variants is the only accurate method of determining mode of inheritance and recurrence risk. Seven individuals with a combination of a recessive pathogenic variant on one allele and a dominantly inherited amino acid substitution on the other allele have been reported, suggesting caution when predicting recurrence risk based on parental phenotype alone (i.e., without molecular genetic testing) [<xref ref-type="bibr" rid="ebd.REF.varki.2007.181">Varki et al 2007</xref>].</p>
          <p>Phenotypic severity and EM/IF findings alone are not sufficient to determine mode of inheritance and recurrence risk, as phenotypic variability is extreme in recessive DEB [<xref ref-type="bibr" rid="ebd.REF.hashimoto.1999.140">Hashimoto et al 1999</xref>, <xref ref-type="bibr" rid="ebd.REF.vaccaro.2000.436">Vaccaro et al 2000</xref>, <xref ref-type="bibr" rid="ebd.REF.mallipeddi.2003.810">Mallipeddi et al 2003</xref>]. An individual with a mild phenotype and no family history may have either autosomal dominant or autosomal recessive DEB; numerous descriptions of the spectrum of phenotypes in RDEB document that some are very mild and mimic DDEB [<xref ref-type="bibr" rid="ebd.REF.hashimoto.1999.140">Hashimoto et al 1999</xref>, <xref ref-type="bibr" rid="ebd.REF.vaccaro.2000.436">Vaccaro et al 2000</xref>, <xref ref-type="bibr" rid="ebd.REF.mallipeddi.2003.810">Mallipeddi et al 2003</xref>, <xref ref-type="bibr" rid="ebd.REF.varki.2007.181">Varki et al 2007</xref>].</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected or at risk.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="ebd.Prenatal_Testing_and_Preimplantation">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p><bold>Molecular genetic testing.</bold> Once the <italic toggle="yes">COL7A1</italic> pathogenic variant(s) have been identified in an affected family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic diagnosis for DEB are possible.</p>
          <p><bold>Fetoscopy.</bold> Electron microscopic evaluation of fetal skin biopsies obtained by fetoscopy is also diagnostic in DEB. Fetoscopy carries a greater risk to pregnancy than CVS or amniocentesis and is performed relatively late (18-20 weeks) in gestation. Prenatal diagnosis for DEB using fetoscopy is not currently available in the US but may be available in Europe.</p>
        </sec>
      </sec>
      <sec id="ebd.Resources">
        <title>Resources</title>
      </sec>
      <sec id="ebd.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="ebd.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <p><italic toggle="yes">COL7A1</italic> is expressed in the keratinocytes including the basal keratinocytes of the epidermis where the protein products are assembled into homotrimeric molecules with a helical triple collagen domain. The homotrimers then associate via disulfide bonds into homodimeric structures in the extracellular matrix below the lamina densa and form the anchoring fibrils that anchor the basement membrane to the underlying dermis. The anchoring fibrils are linked to the basement membrane through attachment to laminin 5 and the keratinocyte hemidesmosomes directly above. The intracellular keratin intermediate filament network is linked directly to the hemidesmosomes that anchor the keratinocytes to the basal lamina and to the desmosomes that lead to strong attachment of the keratinocytes to one another. These associations along with the network itself supply stability and resistance to stress that enable the keratinocytes to maintain their structural integrity during minor trauma and remain anchored to the basement membrane and dermis [<xref ref-type="bibr" rid="ebd.REF.brucknertuderman.1999.122">Bruckner-Tuderman 1999</xref>].</p>
          <p>Mutation of <italic toggle="yes">COL7A1</italic> can lead to reduced resistance to minor trauma and the resulting blistering that is the hallmark of DEB. The type of pathogenic variant, the biochemical properties of the substituted amino acid, and its location in the protein determine the severity of the blistering phenotype (see <xref ref-type="sec" rid="ebd.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</xref>) and inheritance pattern. Pathogenic missense variants predominate in autosomal dominant forms of DEB and may affect the ability of the collagen VII to assemble into a triple helix (its secondary structure) and to form the intracellular network. Null variants predominate in autosomal recessive forms of DEB, and the absence of functional collagen VII and resulting absence of anchoring fibrils lead to the most severe forms of DEB. Intrafamilial phenotypic variability in dominant DEB suggests that other factors can affect the resistance of the cells to friction [<xref ref-type="bibr" rid="ebd.REF.antonlamprecht.2002">Anton-Lamprecht &#x00026; Gedde-Dahl 2002</xref>, <xref ref-type="bibr" rid="ebd.REF.ortizurda.2005.1773">Ortiz-Urda et al 2005</xref>].</p>
          <p>Individuals with recessive DEB, severe generalized (RDEB-sev gen; formerly known as Hallopeau-Siemens type [RDEB-HS]) have a greater-than-90% lifetime risk of aggressive metastasizing squamous cell carcinoma. The reason for the elevated risk has not been clear until recently: <xref ref-type="bibr" rid="ebd.REF.ortizurda.2005.1773">Ortiz-Urda et al [2005]</xref> examined Ras-driven tumorigenesis in RDEB keratinocytes and found that cells lacking collagen VII did not form tumors in mice, whereas those retaining a specific collagen VII fragment (the amino-terminal non-collagenous domain NC1) were tumorigenic. Restoring NC1 expression restored tumorigenicity in collagen VII-deficient cells. They conclude that tumor-stroma interactions mediated by collagen VII promote neoplasia, and retention of NC1 sequences in a subset of individuals with RDEB may be a factor in their increased susceptibility to squamous cell carcinoma.</p>
          <p><bold>Gene structure.</bold> The normal cDNA comprises 9.2 kb with an open reading frame of 8,833 nucleotides encoding 2944 amino acids in 118 exons spanning 32 kb. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="ebd" object-id="ebd.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
          <p><bold>Pathogenic variants.</bold> Glycine substitution variants in the triple helical domain (especially in exons 73, 74, and 75) predominate (&#x0003e;75%) in DDEB. p.Gly2034Arg and p.Gly2043Arg are the most common DDEB-causing pathogenic variants, making up 50% of the dominant pathogenic variants reported in the largest US cohort [<xref ref-type="bibr" rid="ebd.REF.varki.2007.181">Varki et al 2007</xref>]. Glycine substitutions as well as other amino acid substitutions and splice junction variants outside of this region may also be found in dominant DEB; often, however, inheritance pattern cannot be predicted without determination of parental phenotype and corresponding genotype.</p>
          <p>More than 700 recessive DEB-causing variants spanning the entire gene have been described for all forms of DEB [<xref ref-type="bibr" rid="ebd.REF.ashton.1999.232">Ashton et al 1999</xref>, <xref ref-type="bibr" rid="ebd.REF.mellerio.1999b.22">Mellerio et al 1999b</xref>, <xref ref-type="bibr" rid="ebd.REF.whittock.1999.673">Whittock et al 1999</xref>, <xref ref-type="bibr" rid="ebd.REF.gardella.2002a.1456">Gardella et al 2002a</xref>, <xref ref-type="bibr" rid="ebd.REF.murata.2004.442">Murata et al 2004</xref>, <xref ref-type="bibr" rid="ebd.REF.sawamura.2005.543">Sawamura et al 2005</xref>, <xref ref-type="bibr" rid="ebd.REF.varki.2007.181">Varki et al 2007</xref>]. Common pathogenic variants have been described in certain ethnic backgrounds &#x02013; including c.497dupA [<xref ref-type="bibr" rid="ebd.REF.ashton.1999.232">Ashton et al 1999</xref>, <xref ref-type="bibr" rid="ebd.REF.gardella.2002a.1456">Gardella et al 2002a</xref>], c.2470dupG [<xref ref-type="bibr" rid="ebd.REF.mellerio.1999b.22">Mellerio et al 1999b</xref>], c.1732C&#x0003e;T [<xref ref-type="bibr" rid="ebd.REF.whittock.1999.673">Whittock et al 1999</xref>], c.3840delC [<xref ref-type="bibr" rid="ebd.REF.whittock.1999.673">Whittock et al 1999</xref>], and c.4919delG [<xref ref-type="bibr" rid="ebd.REF.whittock.1999.673">Whittock et al 1999</xref>] &#x02013; and are recurrent in the US population. Each, however, accounts for no more than 1%-2% of the total number of pathogenic variants described. Null variants predominate in RDEB, though glycine substitutions and other amino acid substitutions have been described. Milder forms of RDEB are often caused by splice junction variants or other missense variants.</p>
          <table-wrap id="ebd.T.selected_col7a1_pathogenic_variant" orientation="portrait" position="anchor">
            <label>Table 4. </label>
            <caption>
              <p>Selected <italic toggle="yes">COL7A1</italic> Pathogenic Variants</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_ebd.T.selected_col7a1_pathogenic_variant_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change<break/>(Alias&#x000a0;<sup>1</sup>)</th>
                  <th id="hd_h_ebd.T.selected_col7a1_pathogenic_variant_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                  <th id="hd_h_ebd.T.selected_col7a1_pathogenic_variant_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_ebd.T.selected_col7a1_pathogenic_variant_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.497dupA<break/>(c.497insA)</td>
                  <td headers="hd_h_ebd.T.selected_col7a1_pathogenic_variant_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Val168GlyfsTer12</td>
                  <td headers="hd_h_ebd.T.selected_col7a1_pathogenic_variant_1_1_1_3" rowspan="7" valign="middle" align="left" colspan="1">
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nucleotide/157389010">NM_000094.3</ext-link>
                    <break/>
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/4502961">NP_000085.1</ext-link>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_ebd.T.selected_col7a1_pathogenic_variant_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1732C&#x0003e;T</td>
                  <td headers="hd_h_ebd.T.selected_col7a1_pathogenic_variant_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg578Ter</td>
                </tr>
                <tr>
                  <td headers="hd_h_ebd.T.selected_col7a1_pathogenic_variant_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.2470dupG<break/>(c.2470insG)</td>
                  <td headers="hd_h_ebd.T.selected_col7a1_pathogenic_variant_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Asn825LysfsTer41</td>
                </tr>
                <tr>
                  <td headers="hd_h_ebd.T.selected_col7a1_pathogenic_variant_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.3840delC</td>
                  <td headers="hd_h_ebd.T.selected_col7a1_pathogenic_variant_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gly1281ValfsTer44</td>
                </tr>
                <tr>
                  <td headers="hd_h_ebd.T.selected_col7a1_pathogenic_variant_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.4919delG</td>
                  <td headers="hd_h_ebd.T.selected_col7a1_pathogenic_variant_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gly1640ValfsTer70</td>
                </tr>
                <tr>
                  <td headers="hd_h_ebd.T.selected_col7a1_pathogenic_variant_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.6100G&#x0003e;A</td>
                  <td headers="hd_h_ebd.T.selected_col7a1_pathogenic_variant_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gly2034Arg</td>
                </tr>
                <tr>
                  <td headers="hd_h_ebd.T.selected_col7a1_pathogenic_variant_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.6127G&#x0003e;A</td>
                  <td headers="hd_h_ebd.T.selected_col7a1_pathogenic_variant_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gly2043Arg</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
              </fn>
              <fn>
                <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
              </fn>
              <fn id="ebd.TF.4.1">
                <label>1. </label>
                <p>Variant designation that does not conform to current naming conventions</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Normal gene product.</bold> Collagen VII is a monomer of 2944 amino acids that associates into a homotrimer with a triple helical collagenous domain. The homotrimers then associate via disulfide bonds into homodimeric structures that form the anchoring fibrils.</p>
          <p><bold>Abnormal gene product.</bold> In dominant DEB, collagen VII with a glycine substitution in the collagenous domain may result in abnormal triple helical coiling and a partially nonfunctional protein product. These proteins may exhibit altered morphology on electron microscopy while immunofluorescent staining may be normal or slightly reduced in intensity, making diagnosis by immunofluorescent staining of a skin biopsy difficult unless a cleavage plane is present. In addition, in-frame exon skipping may serve to modulate disease severity in recessive disease and generate a partially functional gene product [<xref ref-type="bibr" rid="ebd.REF.mcgrath.1999.314">McGrath et al 1999</xref>, <xref ref-type="bibr" rid="ebd.REF.varki.2007.181">Varki et al 2007</xref>].</p>
        </sec>
      </sec>
      <sec id="ebd.References">
        <title>References</title>
        <sec id="ebd.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="ebd.Literature_Cited.reflist0">
            <ref id="ebd.REF.adairkirk.2012.e45546">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Adair-Kirk</surname>
                    <given-names>TL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Griffin</surname>
                    <given-names>GL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meyer</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kelley</surname>
                    <given-names>DG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miner</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keene</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marinkovich</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruppert</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitto</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Senior</surname>
                    <given-names>RM</given-names>
                  </name>
                </person-group>
                <article-title>Keratinocyte-targeted expression of human laminin &#x003b3;2 rescues skin blistering and early lethality of laminin &#x003b3;2 deficient mice.</article-title>
                <source>PLoS One.</source>
                <year>2012</year>
                <volume>7</volume>
                <fpage>e45546</fpage>
                <pub-id pub-id-type="pmid">23029085</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.almaani.2011.262">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Almaani</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dopping-Hepenstal</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lai-Cheong</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wong</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nanda</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moss</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin&#x000e9;z</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mellerio</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGrath</surname>
                    <given-names>JA</given-names>
                  </name>
                </person-group>
                <article-title>Identical glycine substitution mutations in type VII collagen may underlie both dominant and recessive forms of dystrophic epidermolysis bullosa.</article-title>
                <source>Acta Derm Venereol.</source>
                <year>2011</year>
                <volume>91</volume>
                <fpage>262</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">21448560</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.antonlamprecht.2002">
              <mixed-citation publication-type="book">Anton-Lamprecht I, Gedde-Dahl T. Epidermolysis bullosa. In: Rimoin DL, Connor MJ, Pyeritz RE, Korf BR, Emery AEH, eds. <italic toggle="yes">Principles and Practice of Medical Genetics.</italic> 4 ed. New York, NY: Churchill Livingstone Publishers; 2002</mixed-citation>
            </ref>
            <ref id="ebd.REF.ashton.1999.232">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ashton</surname>
                    <given-names>GH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mellerio</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dunnill</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Milana</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mayou</surname>
                    <given-names>BJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carrera</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGrath</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eady</surname>
                    <given-names>RA</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Recurrent molecular abnormalities in type VII collagen in Southern Italian patients with recessive dystrophic epidermolysis bullosa.</article-title>
                <source>Clin Exp Dermatol</source>
                <volume>24</volume>
                <fpage>232</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">10354186</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.ayman.2002.436">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ayman</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yerebakan</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ciftcioglu</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alpsoy</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>A 13-year-old girl with recessive dystrophic epidermolysis bullosa presenting with squamous cell carcinoma.</article-title>
                <source>Pediatr Dermatol</source>
                <volume>19</volume>
                <fpage>436</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">12383103</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.azizkhan.2006.55">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Azizkhan</surname>
                    <given-names>RG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stehr</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cohen</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wittkugel</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrell</surname>
                    <given-names>MK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lucky</surname>
                    <given-names>AW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hammelman</surname>
                    <given-names>BD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnson</surname>
                    <given-names>ND</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Racadio</surname>
                    <given-names>JM</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Esophageal strictures in children with recessive dystrophic Epidermolysis bullosa: an 11-year experience with fluoroscopically guided balloon dilatation.</article-title>
                <source>J Pediatr Surg</source>
                <volume>41</volume>
                <fpage>55</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">16410108</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.bale.2014">
              <mixed-citation publication-type="confproc">Bale S, Pfendner EG. Exome &#x0201c;slice&#x0201d; sequencing: an alternative to sequential gene sequencing in epidermolysis bullosa (EB). Abstract 485. Nashville, TN: American College of Medical Genetics Annual Clinical Genetics Meeting. 2014.</mixed-citation>
            </ref>
            <ref id="ebd.REF.brucknertuderman.1999.122">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bruckner-Tuderman</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Hereditary skin diseases of anchoring fibrils.</article-title>
                <source>J Dermatol Sci</source>
                <volume>20</volume>
                <fpage>122</fpage>
                <lpage>33</lpage>
                <pub-id pub-id-type="pmid">10379704</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.castillo.2002.535">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Castillo</surname>
                    <given-names>RO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davies</surname>
                    <given-names>YK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>YC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garcia</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Young</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Management of esophageal strictures in children with recessive dystrophic epidermolysis bullosa.</article-title>
                <source>J Pediatr Gastroenterol Nutr</source>
                <volume>34</volume>
                <fpage>535</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">12050581</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.charlesworth.2003.1344">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Charlesworth</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gagnoux-Palacios</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonduelle</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ortonne</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Raeve</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meneguzzi</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Identification of a lethal form of epidermolysis bullosa simplex associated with a homozygous genetic mutation in plectin.</article-title>
                <source>J Invest Dermatol</source>
                <volume>121</volume>
                <fpage>1344</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">14675180</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.chino.2008.803">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chino</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tamai</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamazaki</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Otsuru</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kikuchi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nimura</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Endo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagai</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitto</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kitajima</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaneda</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Bone marrow cell transfer into fetal circulation can ameliorate genetic skin diseases by providing fibroblasts to the skin and inducing immune tolerance.</article-title>
                <source>Am J Pathol.</source>
                <volume>173</volume>
                <fpage>803</fpage>
                <lpage>14</lpage>
                <pub-id pub-id-type="pmid">18688022</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.conget.2010.429">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Conget</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodriguez</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kramer</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Allers</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simon</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palisson</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gonzalez</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yubero</surname>
                    <given-names>MJ</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Replenishment of type VII collagen and re-epithelialization of chronically ulcerated skin after intradermal administration of allogeneic mesenchymal stromal cells in two patients with recessive dystrophic epidermolysis bullosa.</article-title>
                <source>Cytotherapy.</source>
                <volume>12</volume>
                <fpage>429</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">20230217</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.cserhalmifriedman.2001.1327">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cserhalmi-Friedman</surname>
                    <given-names>PB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garzon</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guzman</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martinez-Mir</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chung</surname>
                    <given-names>WK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anyane-Yeboa</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Christiano</surname>
                    <given-names>AM</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Maternal germline mosaicism in dominant dystrophic epidermolysis bullosa.</article-title>
                <source>J Invest Dermatol</source>
                <volume>117</volume>
                <fpage>1327</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">11710955</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.cserhalmifriedman.1999.143">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cserhalmi-Friedman</surname>
                    <given-names>PB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grossman</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karpati</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ahmad</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horvath</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Christiano</surname>
                    <given-names>AM</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Identification of a de novo glycine substitution in the type VII collagen gene in a proband with mild dystrophic epidermolysis bullosa.</article-title>
                <source>Exp Dermatol</source>
                <volume>8</volume>
                <fpage>143</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">10232407</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.de_benedittis.2004.128">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>De Benedittis</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petruzzi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Favia</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Serpico</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Oro-dental manifestations in Hallopeau-Siemens-type recessive dystrophic epidermolysis bullosa.</article-title>
                <source>Clin Exp Dermatol</source>
                <volume>29</volume>
                <fpage>128</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">14987265</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.de_luca.2009.19">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>De Luca</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pellegrini</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mavilio</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Gene therapy of inherited skin adhesion disorders: a critical overview.</article-title>
                <source>Br J Dermatol.</source>
                <volume>161</volume>
                <fpage>19</fpage>
                <lpage>24</lpage>
                <pub-id pub-id-type="pmid">19466960</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.de_rosa.2013.1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>De Rosa</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carulli</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cocchiarella</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quaglino</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Enzo</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Franchini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giannetti</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Santis</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Recchia</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pellegrini</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Luca</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Long-term stability and safety of transgenic cultured epidermal stem cells in gene therapy of junctional epidermolysis bullosa.</article-title>
                <source>Stem Cell Reports.</source>
                <year>2013</year>
                <volume>2</volume>
                <fpage>1</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">24511464</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.dharma.2001.93">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dharma</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moss</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGrath</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mellerio</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ilchyshyn</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Dominant dystrophic epidermolysis bullosa presenting as familial nail dystrophy.</article-title>
                <source>Clin Exp Dermatol</source>
                <volume>26</volume>
                <fpage>93</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">11260188</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.fassihi.2005.1058">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fassihi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Diba</surname>
                    <given-names>VC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wessagowit</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dopping-Hepenstal</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jones</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burrows</surname>
                    <given-names>NP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGrath</surname>
                    <given-names>JA</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Transient bullous dermolysis of the newborn in three generations.</article-title>
                <source>Br J Dermatol</source>
                <volume>153</volume>
                <fpage>1058</fpage>
                <lpage>63</lpage>
                <pub-id pub-id-type="pmid">16225626</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.fine.2014.1103">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fine</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruckner-Tuderman</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eady</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bauer</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bauer</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Has</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heagerty</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hintner</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hovnanian</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jonkman</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leigh</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marinkovich</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martinez</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGrath</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mellerio</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moss</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murrell</surname>
                    <given-names>DF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimizu</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitto</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Woodley</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zambruno</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <article-title>Inherited epidermolysis bullosa: Updated recommendations on diagnosis and classification.</article-title>
                <source>J Am Acad Dermatol.</source>
                <year>2014</year>
                <volume>70</volume>
                <fpage>1103</fpage>
                <lpage>26</lpage>
                <pub-id pub-id-type="pmid">24690439</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.fine.2009.203">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fine</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnson</surname>
                    <given-names>LB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weiner</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>KP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suchindran</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Epidermolysis bullosa and the risk of life-threatening cancers: the National EB Registry experience, 1986-2006.</article-title>
                <source>J Am Acad Dermatol.</source>
                <volume>60</volume>
                <fpage>203</fpage>
                <lpage>11</lpage>
                <pub-id pub-id-type="pmid">19026465</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.fine.2004.651">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fine</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnson</surname>
                    <given-names>LB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weiner</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stein</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cash</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DeLeoz</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Devries</surname>
                    <given-names>DT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suchindran</surname>
                    <given-names>C</given-names>
                  </name>
                  <collab>National Epidermolysis Bullosa Registry</collab>
                </person-group>
                <year>2004</year>
                <article-title>Inherited epidermolysis bullosa and the risk of death from renal disease: experience of the National Epidermolysis Bullosa Registry.</article-title>
                <source>Am J Kidney Dis.</source>
                <volume>44</volume>
                <fpage>651</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">15384016</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.fine.2009a.367">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fine</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mellerio</surname>
                    <given-names>JE</given-names>
                  </name>
                </person-group>
                <year>2009a</year>
                <article-title>Extracutaneous manifestations and complications of inherited epidermolysis bullosa: part I. Epithelial associated tissues.</article-title>
                <source>J Am Acad Dermatol.</source>
                <volume>61</volume>
                <fpage>367</fpage>
                <lpage>84</lpage>
                <pub-id pub-id-type="pmid">19700010</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.fine.2009b.387">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fine</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mellerio</surname>
                    <given-names>JE</given-names>
                  </name>
                </person-group>
                <year>2009b</year>
                <article-title>Extracutaneous manifestations and complications of inherited epidermolysis bullosa: part II. Other organs.</article-title>
                <source>J Am Acad Dermatol.</source>
                <volume>61</volume>
                <fpage>387</fpage>
                <lpage>402</lpage>
                <pub-id pub-id-type="pmid">19700011</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.frew.2010.185">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Frew</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murrell</surname>
                    <given-names>DF</given-names>
                  </name>
                </person-group>
                <article-title>Quality of life measurements in epidermolysis bullosa: tools for clinical research and patient care.</article-title>
                <source>Dermatol Clin.</source>
                <year>2010</year>
                <volume>28</volume>
                <fpage>185</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">19945634</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.fritsch.2008.1669">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fritsch</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loeckermann</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kern</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Braun</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>B&#x000f6;sl</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bley</surname>
                    <given-names>TA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schumann</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>von Elverfeldt</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paul</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Erlacher</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berens von Rautenfeld</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hausser</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>F&#x000e4;ssler</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruckner-Tuderman</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>A hypomorphic mouse model of dystrophic epidermolysis bullosa reveals mechanisms of disease and response to fibroblast therapy.</article-title>
                <source>J Clin Invest.</source>
                <volume>118</volume>
                <fpage>1669</fpage>
                <lpage>79</lpage>
                <pub-id pub-id-type="pmid">18382769</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.fujita.2010.14345">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fujita</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abe</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inokuma</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sasaki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoshina</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Natsuga</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishie</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McMillan</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakamura</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimizu</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Akiyama</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sawamura</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimizu</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Bone marrow transplantation restores epidermal basement membrane protein expression and rescues epidermolysis bullosa model mice.</article-title>
                <source>Proc Natl Acad Sci U S A.</source>
                <volume>107</volume>
                <fpage>14345</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">20660747</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.gardella.2002a.1456">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gardella</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Castiglia</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Posteraro</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernardini</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zoppi</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paradisi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tadini</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barlati</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGrath</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zambruno</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Colombi</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2002a</year>
                <article-title>Genotype-phenotype correlation in italian patients with dystrophic epidermolysis bullosa.</article-title>
                <source>J Invest Dermatol</source>
                <volume>119</volume>
                <fpage>1456</fpage>
                <lpage>62</lpage>
                <pub-id pub-id-type="pmid">12485454</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.gardella.2002b.450">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gardella</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zoppi</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zambruno</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barlati</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Colombi</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2002b</year>
                <article-title>Different phenotypes in recessive dystrophic epidermolysis bullosa patients sharing the same mutation in compound heterozygosity with two novel mutations in the type VII collagen gene.</article-title>
                <source>Br J Dermatol</source>
                <volume>147</volume>
                <fpage>450</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">12207583</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.glicenstein.2000.637">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Glicenstein</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mariani</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haddad</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>The hand in recessive dystrophic epidermolysis bullosa.</article-title>
                <source>Hand Clin</source>
                <volume>16</volume>
                <fpage>637</fpage>
                <lpage>45</lpage>
                <pub-id pub-id-type="pmid">11117053</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.gosty_ski.2014.98">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gosty&#x00144;ski</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pasmooij</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jonkman</surname>
                    <given-names>MF</given-names>
                  </name>
                </person-group>
                <article-title>Successful therapeutic transplantation of revertant skin in epidermolysis bullosa.</article-title>
                <source>J Am Acad Dermatol.</source>
                <year>2014</year>
                <volume>70</volume>
                <fpage>98</fpage>
                <lpage>101</lpage>
                <pub-id pub-id-type="pmid">24176523</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.harris.2001.438">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Harris</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bryan</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lucas</surname>
                    <given-names>VS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roberts</surname>
                    <given-names>GJ</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Dental disease and caries related microflora in children with dystrophic epidermolysis bullosa.</article-title>
                <source>Pediatr Dent</source>
                <volume>23</volume>
                <fpage>438</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">11699172</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.hashimoto.1999.140">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hashimoto</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kon</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tamai</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitto</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Diagnostic dilemma of "sporadic" cases of dystrophic epidermolysis bullosa: a new dominant or mitis recessive mutation?</article-title>
                <source>Exp Dermatol</source>
                <volume>8</volume>
                <fpage>140</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">10232406</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.haynes.1996.872">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Haynes</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Atherton</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ade-Ajayi</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wheeler</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kiely</surname>
                    <given-names>EM</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>Gastrostomy and growth in dystrophic epidermolysis bullosa.</article-title>
                <source>Br J Dermatol</source>
                <volume>134</volume>
                <fpage>872</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">8736328</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.hovnanian.2013.1719">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hovnanian</surname>
                    <given-names>A.</given-names>
                  </name>
                </person-group>
                <article-title>Systemic protein therapy for recessive dystrophic epidermolysis bullosa: how far are we from clinical translation?</article-title>
                <source>J Invest Dermatol.</source>
                <year>2013</year>
                <volume>133</volume>
                <fpage>1719</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">23760051</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.ito.2009.2508">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ito</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sawamura</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goto</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakamura</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishie</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sakai</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Natsuga</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shinkuma</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shibaki</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitto</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Denton</surname>
                    <given-names>CP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakajima</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Akiyama</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimizu</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Keratinocyte-/fibroblast-targeted rescue of Col7a1-disrupted mice and generation of an exact dystrophic epidermolysis bullosa model using a human COL7A1 mutation.</article-title>
                <source>Am J Pathol.</source>
                <volume>175</volume>
                <fpage>2508</fpage>
                <lpage>17</lpage>
                <pub-id pub-id-type="pmid">19893033</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.itoh.2013.e77673">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Itoh</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Umegaki-Arao</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guo</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Higgins</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Christiano</surname>
                    <given-names>AM</given-names>
                  </name>
                </person-group>
                <article-title>Generation of 3D skin equivalents fully reconstituted from human induced pluripotent stem cells (iPSCs).</article-title>
                <source>PLoS One.</source>
                <year>2013</year>
                <volume>8</volume>
                <fpage>e77673</fpage>
                <pub-id pub-id-type="pmid">24147053</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.jobard.2003.925">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jobard</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bouadjar</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caux</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hadj-Rabia</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Has</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsuda</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weissenbach</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lathrop</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prud'homme</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fischer</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Identification of mutations in a new gene encoding a FERM family protein with a pleckstrin homology domain in Kindler syndrome.</article-title>
                <source>Hum Mol Genet.</source>
                <volume>12</volume>
                <fpage>925</fpage>
                <lpage>35</lpage>
                <pub-id pub-id-type="pmid">12668616</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.kay.2002.515">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kay</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wyllie</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Endoscopic dilatation of esophageal strictures in recessive dystrophic epidermolysis bullosa: new equipment, new techniques.</article-title>
                <source>J Pediatr Gastroenterol Nutr</source>
                <volume>34</volume>
                <fpage>515</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">12050577</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.kern.2006.1006">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kern</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kohlhase</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruckner-Tuderman</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Has</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Expanding the COL7A1 mutation database: novel and recurrent mutations and unusual genotype-phenotype constellations in 41 patients with dystrophic epidermolysis bullosa.</article-title>
                <source>J Invest Dermatol</source>
                <volume>126</volume>
                <fpage>1006</fpage>
                <lpage>12</lpage>
                <pub-id pub-id-type="pmid">16484981</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.kossharnes.2004.124">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Koss-Harnes</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoyheim</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jonkman</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Groot</surname>
                    <given-names>WP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Weerdt</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nikolic</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wiche</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gedde-Dahl</surname>
                    <given-names>T</given-names>
                    <suffix>Jr</suffix>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Life-long course and molecular characterization of the original Dutch family with epidermolysis bullosa simplex with muscular dystrophy due to a homozygous novel plectin point mutation.</article-title>
                <source>Acta Derm Venereol</source>
                <volume>84</volume>
                <fpage>124</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">15206692</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.lanschuetzer.2010.179">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lanschuetzer</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laimer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nischler</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hintner</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Epidermolysis bullosa nevi.</article-title>
                <source>Dermatol Clin.</source>
                <volume>28</volume>
                <fpage>179</fpage>
                <lpage>83</lpage>
                <pub-id pub-id-type="pmid">19945633</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.laracorrales.2010.238">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lara-Corrales</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mellerio</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martinez</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Green</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lucky</surname>
                    <given-names>AW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Azizkhan</surname>
                    <given-names>RG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murrell</surname>
                    <given-names>DF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Agero</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kantor</surname>
                    <given-names>PF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pope</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <article-title>Dilated cardiomyopathy in epidermolysis bullosa: a retrospective, multicenter study.</article-title>
                <source>Pediatr Dermatol.</source>
                <year>2010</year>
                <volume>27</volume>
                <fpage>238</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">20609141</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.liao.2014.303">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Liao</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Itoh</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhu</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roberts</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Highet</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Latshaw</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitchell</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van de Ven</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Christiano</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cairo</surname>
                    <given-names>MS</given-names>
                  </name>
                </person-group>
                <article-title>Human cord blood-derived unrestricted somatic stem cells promote wound healing and have therapeutic potential for patients with recessive dystrophic epidermolysis bullosa.</article-title>
                <source>Cell Transplant.</source>
                <year>2014</year>
                <volume>23</volume>
                <fpage>303</fpage>
                <lpage>17</lpage>
                <pub-id pub-id-type="pmid">23394106</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.mallipeddi.2003.810">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mallipeddi</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bleck</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mellerio</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ashton</surname>
                    <given-names>GH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eady</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGrath</surname>
                    <given-names>JA</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Dilemmas in distinguishing between dominant and recessive forms of dystrophic epidermolysis bullosa.</article-title>
                <source>Br J Dermatol</source>
                <volume>149</volume>
                <fpage>810</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">14616374</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.mar_nbertol_n.1999.555">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mar&#x000ed;n-Bertol&#x000ed;n</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amaya Valero</surname>
                    <given-names>JV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neira Gimenez</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marquina Vila</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amorrortu-Velayos</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Surgical management of hand contractures and pseudosyndactyly in dystrophic epidermolysis bullosa.</article-title>
                <source>Ann Plast Surg</source>
                <volume>43</volume>
                <fpage>555</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">10560876</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.matsumoto.2005.474">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Matsumoto</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dogru</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsubota</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Ocular surface findings in Hallopeau-Siemens subtype of dystrophic epidermolysis bullosa: report of a case and literature review.</article-title>
                <source>Cornea</source>
                <volume>24</volume>
                <fpage>474</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">15829808</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.mcgrath.1999.314">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>McGrath</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ashton</surname>
                    <given-names>GH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mellerio</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salas-Alanis</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Swensson</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McMillan</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eady</surname>
                    <given-names>RA</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Moderation of phenotypic severity in dystrophic and junctional forms of epidermolysis bullosa through in-frame skipping of exons containing non-sense or frameshift mutations.</article-title>
                <source>J Invest Dermatol</source>
                <volume>113</volume>
                <fpage>314</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">10469327</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.mellerio.1999a.984">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mellerio</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ashton</surname>
                    <given-names>GH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mohammedi</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lyon</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kirby</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harman</surname>
                    <given-names>KE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salas-Alanis</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Atherton</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harrison</surname>
                    <given-names>PV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Griffiths</surname>
                    <given-names>WA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Black</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eady</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGrath</surname>
                    <given-names>JA</given-names>
                  </name>
                </person-group>
                <year>1999a</year>
                <article-title>Allelic heterogeneity of dominant and recessive COL7A1 mutations underlying epidermolysis bullosa pruriginosa.</article-title>
                <source>J Invest Dermatol</source>
                <volume>112</volume>
                <fpage>984</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">10383749</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.mellerio.1999b.22">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mellerio</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salas-Alanis</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amaya-Guerra</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tamez</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ashton</surname>
                    <given-names>GH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mohammedi</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eady</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGrath</surname>
                    <given-names>JA</given-names>
                  </name>
                </person-group>
                <year>1999b</year>
                <article-title>A recurrent frameshift mutation in exon 19 of the type VII collagen gene (COL7A1) in Mexican patients with recessive dystrophic epidermolysis bullosa.</article-title>
                <source>Exp Dermatol</source>
                <volume>8</volume>
                <fpage>22</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">10206718</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.melo.2014.725">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Melo</surname>
                    <given-names>SP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lisowski</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bashkirova</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhen</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chu</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keene</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marinkovich</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kay</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oro</surname>
                    <given-names>AE</given-names>
                  </name>
                </person-group>
                <article-title>Somatic correction of junctional epidermolysis bullosa by a highly recombinogenic AAV variant.</article-title>
                <source>Mol Ther.</source>
                <year>2014</year>
                <volume>22</volume>
                <fpage>725</fpage>
                <lpage>33</lpage>
                <pub-id pub-id-type="pmid">24390279</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.murata.2004.442">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Murata</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Masunaga</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ishiko</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimizu</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishikawa</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Differences in recurrent COL7A1 mutations in dystrophic epidermolysis bullosa: ethnic-specific and worldwide recurrent mutations.</article-title>
                <source>Arch Dermatol Res</source>
                <volume>295</volume>
                <fpage>442</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">14727126</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.murata.2000.477">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Murata</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Masunaga</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimizu</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takizawa</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ishiko</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hatta</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishikawa</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Glycine substitution mutations by different amino acids in the same codon of COL7A1 lead to heterogeneous clinical phenotypes of dominant dystrophic epidermolysis bullosa.</article-title>
                <source>Arch Dermatol Res</source>
                <volume>292</volume>
                <fpage>477</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">11142768</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.murrell.2010">
              <mixed-citation publication-type="book">Murrell D. <italic toggle="yes">Epidermolysis Bullosa: Part I &#x02013; Pathogenesis and Clinical Features</italic>. 1 ed. Vol 28-1. Dermatologic Clinics, Elsevier; 2010.</mixed-citation>
            </ref>
            <ref id="ebd.REF.nakamura.2004.195">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nakamura</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sawamura</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goto</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sato-Matsumura</surname>
                    <given-names>KC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>LaDuca</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>JY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Masunaga</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimizu</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>The G2028R glycine substitution mutation in COL7A1 leads to marked inter-familiar clinical heterogeneity in dominant dystrophic epidermolysis bullosa.</article-title>
                <source>J Dermatol Sci</source>
                <volume>34</volume>
                <fpage>195</fpage>
                <lpage>200</lpage>
                <pub-id pub-id-type="pmid">15113589</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.ortizurda.2005.1773">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ortiz-Urda</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garcia</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Green</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Veitch</surname>
                    <given-names>DP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sakai</surname>
                    <given-names>LY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marinkovich</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khavari</surname>
                    <given-names>PA</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Type VII collagen is required for Ras-driven human epidermal tumorigenesis.</article-title>
                <source>Science</source>
                <volume>307</volume>
                <fpage>1773</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">15774758</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.ortizurda.2003.251">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ortiz-Urda</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Green</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keene</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marinkovich</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khavari</surname>
                    <given-names>PA</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Injection of genetically engineered fibroblasts corrects regenerated human epidermolysis bullosa skin tissue.</article-title>
                <source>J Clin Invest.</source>
                <volume>111</volume>
                <fpage>251</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">12531881</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.osborn.2013.1151">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Osborn</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Starker</surname>
                    <given-names>CG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McElroy</surname>
                    <given-names>AN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Webber</surname>
                    <given-names>BR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Riddle</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xia</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DeFeo</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gabriel</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmidt</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>von Kalle</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carlson</surname>
                    <given-names>DF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maeder</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joung</surname>
                    <given-names>JK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wagner</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Voytas</surname>
                    <given-names>DF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blazar</surname>
                    <given-names>BR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tolar</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>TALEN-based gene correction for epidermolysis bullosa.</article-title>
                <source>Mol Ther.</source>
                <year>2013</year>
                <volume>21</volume>
                <fpage>1151</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">23546300</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.pfendner.2005.241">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pfendner</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rouan</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitto</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Progress in epidermolysis bullosa: the phenotypic spectrum of plectin mutations.</article-title>
                <source>Exp Dermatol</source>
                <volume>14</volume>
                <fpage>241</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">15810881</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.pfendner.2005.111">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pfendner</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitto</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Plectin gene mutations can cause epidermolysis bullosa with pyloric atresia.</article-title>
                <source>J Invest Dermatol</source>
                <volume>124</volume>
                <fpage>111</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">15654962</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.pfendner.2001.483">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pfendner</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitto</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fine</surname>
                    <given-names>JD</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Epidermolysis bullosa carrier frequencies in the US population.</article-title>
                <source>J Invest Dermatol</source>
                <volume>116</volume>
                <fpage>483</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">11231335</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.pope.2012.904">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pope</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lara-Corrales</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mellerio</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martinez</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schultz</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burrell</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goodman</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coutts</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wagner</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Allen</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sibbald</surname>
                    <given-names>G.</given-names>
                  </name>
                </person-group>
                <article-title>A consensus approach to&#x000a0;wound&#x000a0;care&#x000a0;in&#x000a0;epidermolysis bullosa.</article-title>
                <source>J Am Acad Dermatol.</source>
                <year>2012</year>
                <volume>67</volume>
                <fpage>904</fpage>
                <lpage>17</lpage>
                <pub-id pub-id-type="pmid">22387035</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.remington.2009.26">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Remington</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hou</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhou</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burnett</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muirhead</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitto</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keene</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Woodley</surname>
                    <given-names>DT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Injection of recombinant human type VII collagen corrects the disease phenotype in a murine model of dystrophic epidermolysis bullosa.</article-title>
                <source>Mol Ther.</source>
                <volume>17</volume>
                <fpage>26</fpage>
                <lpage>33</lpage>
                <pub-id pub-id-type="pmid">19018253</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.satomatsumura.2002.269">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sato-Matsumura</surname>
                    <given-names>KC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yasukawa</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tomita</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimizu</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Toenail dystrophy with COL7A1 glycine substitution mutations segregates as an autosomal dominant trait in 2 families with dystrophic epidermolysis bullosa.</article-title>
                <source>Arch Dermatol</source>
                <volume>138</volume>
                <fpage>269</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">11843659</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.sawamura.2005.543">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sawamura</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goto</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yasukawa</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sato-Matsumura</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakamura</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ito</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakamura</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tomita</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimizu</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Genetic studies of 20 Japanese families of dystrophic epidermolysis bullosa.</article-title>
                <source>J Hum Genet</source>
                <volume>50</volume>
                <fpage>543</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">16189623</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.schara.2004.218">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schara</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tucke</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mortier</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nusslein</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rouan</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pfendner</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zillikens</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruckner-Tuderman</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitto</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wiche</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schroder</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Severe mucous membrane involvement in epidermolysis bullosa simplex with muscular dystrophy due to a novel plectin gene mutation.</article-title>
                <source>Eur J Pediatr</source>
                <volume>163</volume>
                <fpage>218</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">14963703</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.serranomart_nez.2003.264">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Serrano-Mart&#x000ed;nez</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bagan</surname>
                    <given-names>JV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Silvestre</surname>
                    <given-names>FJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Viguer</surname>
                    <given-names>MT</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Oral lesions in recessive dystrophic epidermolysis bullosa.</article-title>
                <source>Oral Dis</source>
                <volume>9</volume>
                <fpage>264</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">14628894</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.sidwell.2000.59">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sidwell</surname>
                    <given-names>RU</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yates</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Atherton</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Dilated cardiomyopathy in dystrophic epidermolysis bullosa.</article-title>
                <source>Arch Dis Child</source>
                <volume>83</volume>
                <fpage>59</fpage>
                <lpage>63</lpage>
                <pub-id pub-id-type="pmid">10869001</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.siegel.2003.174">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Siegel</surname>
                    <given-names>DH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ashton</surname>
                    <given-names>GH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Penagos</surname>
                    <given-names>HG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>JV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feiler</surname>
                    <given-names>HS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilhelmsen</surname>
                    <given-names>KC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>South</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>FJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prescott</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wessagowit</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oyama</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Akiyama</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al Aboud</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al Aboud</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al Githami</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al Hawsawi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al Ismaily</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Suwaid</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Atherton</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caputo</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fine</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frieden</surname>
                    <given-names>IJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fuchs</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haber</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harada</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kitajima</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mallory</surname>
                    <given-names>SB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ogawa</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sahin</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimizu</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suga</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tadini</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsuchiya</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wiebe</surname>
                    <given-names>CB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wojnarowska</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zaghloul</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamada</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mallipeddi</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eady</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McLean</surname>
                    <given-names>WH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGrath</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Epstein</surname>
                    <given-names>EH</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Loss of kindlin-1, a human homolog of the Caenorhabditis elegans actin-extracellular-matrix linker protein UNC-112, causes Kindler syndrome.</article-title>
                <source>Am J Hum Genet.</source>
                <volume>73</volume>
                <fpage>174</fpage>
                <lpage>87</lpage>
                <pub-id pub-id-type="pmid">12789646</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.siprashvili.2010.1299">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Siprashvili</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nguyen</surname>
                    <given-names>NT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bezchinsky</surname>
                    <given-names>MY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marinkovich</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lane</surname>
                    <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khavari</surname>
                    <given-names>PA</given-names>
                  </name>
                </person-group>
                <article-title>Long-term type VII collagen restoration to human epidermolysis bullosa skin tissue.</article-title>
                <source>Hum Gene Ther.</source>
                <year>2010</year>
                <volume>21</volume>
                <fpage>1299</fpage>
                <lpage>310</lpage>
                <pub-id pub-id-type="pmid">20497034</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.siprashvili.2014">
              <mixed-citation publication-type="confproc">Siprashvili Z, Nguyen NT, Gorell E, Khuu P, Furukawa L, Lorenz HP, Leung TH, Keene DR, Khavari PA, Marinkovich MP, Lane AT, Phase I clinical trial of genetically corrected autologous epidermal keratinocytes for recessive dystrophic epidermolysis bullosa. Abstract #430. Albuquerque, NM: Society for Investigative Dermatology Annual Meeting; 2014.</mixed-citation>
            </ref>
            <ref id="ebd.REF.stehr.2008.349">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Stehr</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrell</surname>
                    <given-names>MK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lucky</surname>
                    <given-names>AW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnson</surname>
                    <given-names>ND</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Racadio</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Azizkhan</surname>
                    <given-names>RG</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Non-endoscopic percutaneous gastrostomy placement in children with recessive dystrophic epidermolysis bullosa.</article-title>
                <source>Pediatr Surg Int.</source>
                <volume>24</volume>
                <fpage>349</fpage>
                <lpage>54</lpage>
                <pub-id pub-id-type="pmid">18094979</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.tamai.1999.991">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tamai</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murai</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mayama</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kon</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nomura</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sawamura</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanada</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hashimoto</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimizu</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Masunaga</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishikawa</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitsuhashi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ishida-Yamamoto</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ikeda</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ogawa</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGrath</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pulkkinen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitto</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Recurrent COL7A1 mutations in Japanese patients with dystrophic epidermolysis bullosa: positional effects of premature termination codon mutations on clinical severity. Japanese Collaborative Study Group on Epidermolysis Bullosa.</article-title>
                <source>J Invest Dermatol</source>
                <volume>112</volume>
                <fpage>991</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">10383751</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.titeux.2010.361">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Titeux</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pendaries</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hovnanian</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Gene therapy for recessive dystrophic epidermolysis bullosa.</article-title>
                <source>Dermatol Clin.</source>
                <volume>28</volume>
                <fpage>361</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">20447504</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.tolar.2009.1167">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tolar</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ishida-Yamamoto</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Riddle</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McElmurry</surname>
                    <given-names>RT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Osborn</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xia</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lund</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Slattery</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitto</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Christiano</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wagner</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blazar</surname>
                    <given-names>BR</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Amelioration of epidermolysis bullosa by transfer of wild-type bone marrow cells.</article-title>
                <source>Blood.</source>
                <volume>113</volume>
                <fpage>1167</fpage>
                <lpage>74</lpage>
                <pub-id pub-id-type="pmid">18955559</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.tolar.2014.1246">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tolar</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGrath</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xia</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Riddle</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lees</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eide</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keene</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Osborn</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lund</surname>
                    <given-names>TC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blazar</surname>
                    <given-names>BR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wagner</surname>
                    <given-names>JE</given-names>
                  </name>
                </person-group>
                <article-title>Patient-specific naturally gene-reverted induced pluripotent stem cells in recessive dystrophic epidermolysis bullosa.</article-title>
                <source>J Invest Dermatol.</source>
                <year>2014</year>
                <volume>134</volume>
                <fpage>1246</fpage>
                <lpage>54</lpage>
                <pub-id pub-id-type="pmid">24317394</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.tolar.2013.1214">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tolar</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wagner</surname>
                    <given-names>JE</given-names>
                  </name>
                </person-group>
                <article-title>Allogeneic blood and bone marrow cells for the treatment of severe epidermolysis bullosa: repair of the extracellular matrix.</article-title>
                <source>Lancet.</source>
                <year>2013</year>
                <volume>382</volume>
                <fpage>1214</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">24095195</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.tosti.2003.456">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tosti</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piraccini</surname>
                    <given-names>BM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scher</surname>
                    <given-names>RK</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Isolated nail dystrophy suggestive of dominant dystrophic epidermolysis bullosa.</article-title>
                <source>Pediatr Dermatol</source>
                <volume>20</volume>
                <fpage>456</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">14521572</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.vaccaro.2000.436">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vaccaro</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moretti</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guarneri</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cannavo</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Magaudda</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>"Sporadic" dystrophic epidermolysis bullosa: a new dominant or mitis recessive mutation?</article-title>
                <source>Eur J Dermatol</source>
                <volume>10</volume>
                <fpage>436</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">10980463</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.varki.2007.181">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Varki</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sadowski</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitto</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pfendner</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Epidermolysis bullosa. II. Type VII collagen mutations and phenotype-genotype correlations in the dystrophic subtypes.</article-title>
                <source>J Med Genet.</source>
                <volume>44</volume>
                <fpage>181</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">16971478</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.venugopal.2013.898">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Venugopal</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yan</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frew</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cohn</surname>
                    <given-names>HI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rhodes</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tran</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Melbourne</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nelson</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sturm</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fogarty</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marinkovich</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Igawa</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ishida-Yamamoto</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murrell</surname>
                    <given-names>DF</given-names>
                  </name>
                </person-group>
                <article-title>A phase II randomized vehicle-controlled trial of intradermal allogeneic fibroblasts for recessive dystrophic epidermolysis bullosa.</article-title>
                <source>J Am Acad Dermatol.</source>
                <year>2013</year>
                <volume>69</volume>
                <fpage>898</fpage>
                <lpage>908.e7</lpage>
                <pub-id pub-id-type="pmid">24075228</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.wagner.2010.629">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wagner</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ishida-Yamamoto</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGrath</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hordinsky</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keene</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Woodley</surname>
                    <given-names>DT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Riddle</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Osborn</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lund</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dolan</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blazar</surname>
                    <given-names>BR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tolar</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Bone marrow transplantation for recessive dystrophic epidermolysis bullosa.</article-title>
                <source>N Engl J Med.</source>
                <volume>363</volume>
                <fpage>629</fpage>
                <lpage>39</lpage>
                <pub-id pub-id-type="pmid">20818854</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.wang.2013.1335">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ghasri</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amir</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hwang</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hou</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khalili</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keene</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitto</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Woodley</surname>
                    <given-names>DT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Topical application of recombinant type VII collagen incorporates into the dermal-epidermal junction and promotes wound closure.</article-title>
                <source>Mol Ther.</source>
                <year>2013</year>
                <volume>21</volume>
                <fpage>1335</fpage>
                <lpage>44</lpage>
                <pub-id pub-id-type="pmid">23670575</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.wessagowit.2001.97">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wessagowit</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ashton</surname>
                    <given-names>GH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mohammedi</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salas-Alanis</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Denyer</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mellerio</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eady</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGrath</surname>
                    <given-names>JA</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Three cases of de novo dominant dystrophic epidermolysis bullosa associated with the mutation G2043R in COL7A1.</article-title>
                <source>Clin Exp Dermatol</source>
                <volume>26</volume>
                <fpage>97</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">11260189</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.wessagowit.2005.863">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wessagowit</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Woong Oh</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGrath</surname>
                    <given-names>JA</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Genotype-phenotype correlation in recessive dystrophic epidermolysis bullosa: when missense doesn't make sense.</article-title>
                <source>J Invest Dermatol</source>
                <volume>124</volume>
                <fpage>863</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">15816848</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.whittock.1999.673">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Whittock</surname>
                    <given-names>NV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ashton</surname>
                    <given-names>GH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mohammedi</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mellerio</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mathew</surname>
                    <given-names>CG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abbs</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eady</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGrath</surname>
                    <given-names>JA</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Comparative mutation detection screening of the type VII collagen gene (COL7A1) using the protein truncation test, fluorescent chemical cleavage of mismatch, and conformation sensitive gel electrophoresis.</article-title>
                <source>J Invest Dermatol</source>
                <volume>113</volume>
                <fpage>673</fpage>
                <lpage>86</lpage>
                <pub-id pub-id-type="pmid">10504458</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.wong.2008.2179">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wong</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gammon</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mellerio</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dopping-Hepenstal</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pacy</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elia</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jeffery</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leigh</surname>
                    <given-names>IM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Navsaria</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGrath</surname>
                    <given-names>JA</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa.</article-title>
                <source>J Invest Dermatol.</source>
                <volume>128</volume>
                <fpage>2179</fpage>
                <lpage>89</lpage>
                <pub-id pub-id-type="pmid">18385758</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.woodley.2013.1910">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Woodley</surname>
                    <given-names>DT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amir</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hwang</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Remington</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hou</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitto</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keene</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Intravenously injected recombinant human type VII collagen homes to skin wounds and restores skin integrity of dystrophic epidermolysis bullosa.</article-title>
                <source>J Invest Dermatol.</source>
                <year>2013</year>
                <volume>133</volume>
                <fpage>1910</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">23321924</pub-id>
              </element-citation>
            </ref>
            <ref id="ebd.REF.zimmer.2002.220">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zimmer</surname>
                    <given-names>KP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schumann</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mecklenbeck</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruckner-Tuderman</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Esophageal stenosis in childhood: dystrophic epidermolysis bullosa without skin blistering due to collagen VII mutations.</article-title>
                <source>Gastroenterology</source>
                <volume>122</volume>
                <fpage>220</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">11781296</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="ebd.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="ebd.Author_Notes">
          <title>Author Notes</title>
          <p>GeneDx <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.genedx.com/">Web site</ext-link></p>
          <p>Cincinnati Children&#x02019;s Epidermolysis Bullosa Center <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.cincinnatichildrens.org/eb-center">Web site</ext-link></p>
        </sec>
        <sec id="ebd.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>26 February 2015 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>4 November 2010 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>4 October 2007 (cd) Revision: deletion/duplication analysis available on a clinical basis</p>
            </list-item>
            <list-item>
              <p>21 September 2007 (cd) Revision: deletion/duplication analysis no longer available on a clinical basis</p>
            </list-item>
            <list-item>
              <p>17 October 2006 (cd) Revision: deletion/duplication analysis available on a clinical basis</p>
            </list-item>
            <list-item>
              <p>21 August 2006 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>27 December 2005 (ep) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec sec-type="figs-and-tables">
        <title/>
        <fig position="float" id="ebd.F1" orientation="portrait">
          <label>Figure 1. </label>
          <caption>
            <p>Common findings of dystrophic epidermolysis bullosa:a,b: Scarring on knees and hands and dystrophic nails found in dominant DEB in an adultc: Aplasia cutis congenita in a newborn with recessive DEBd: Generalized blistering in a child with recessive DEBe: Scarring of feet with pseudosyndactyly of toes caused by scarring in recessive DEBf: Severe generalized blistering in recessive DEB in an adultg: Severe generalized scarring in a young adult with recessive DEBh: Pseudosyndactyly caused by scarring in recessive DEB in an adult</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ebd-Image001" position="anchor" orientation="portrait"/>
        </fig>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
